About the Service
Our modern laboratory has state-of-the-art instruments which are kept controlled and calibrated by a rigorous preventive maintenance program, as well as external quality control with the CAP (College of American Pathologists) and following JCI (Joint Commission International) standards. .
We have a variety of tests and services in the area of General and Special Hematology, General and Special Chemistry, Immunoserology, Microbiology (including fungi and mycobacteria), Quantitative Urinary Analysis, General Parasitology, and Molecular Tests.
Office Hours
Outpatient Center, located next to the Main entrance of San Fernando Hospital Clinic. Opening hours: Monday to Friday, from 6:00 am to 7:00 pm and Saturdays from 6:00 am to 2:00 pm
Contact
Telephone: (507) 305-6300 ext. 8176
Quality and Excellence
Our laboratory has the most complete external quality controls, performing proficiency tests from internationally recognized entities, to ensure the quality and safety of the tests that are efficiently executed by highly trained personnel committed to providing the best care:
CAP (College of American Pathologists), USA, since 2000.
EQAS (External Quality Assurance Services), BIORAD, USA.
CDC (Centers for Disease Control and Prevention), Newborn Screening Quality Assurance Program, USA.
PEEC (External Quality Assessment Program), Neonatal Screening, Argentina.
As well as subscription in:
CLSI (Clinical Laboratory Standards Institute).
Others
We offer the use of reference laboratories in the Republic of Panama and the United States. The San Fernando Clinical laboratory is responsible for the pre-analytical process, data verification, extraction, identification and adequate conservation of the samples. The logistics of transporting the samples to facilities in the United States is the responsibility of an external agency that receives the analysis reports, delivers the originals to the San Fernando Clinical Laboratory, and immediately notifies any critical value that the reference laboratory highlights.
The continuous improvement plan for services and performance is an important part of our management. We implement in our service the programs of Customer Service, Management of the Use of Resources, Organizational Assessment and Risk Management. In addition, the San Fernando Clinical Laboratory has active participation in the Quality, Epidemiology, Biosafety and Evacuation / Disaster Committees at the hospital level.
Below you will find an alphabetical list of all the tests that we are capable of performing at Clínica Hospital San Fernando
A
ACETAMINOPHEN
Indications: Sampling before the next dose of acetaminophen. Synonyms Anacin-3, P-Acetaminophenol, N-Acetyl-P-Aminophenol, Paracetamol, Phenaphen, Excedrine®, NAPA, Tempra®, Datril®, Panadol®, Tylenol®.
Indications: Sampling before the next dose of acetaminophen. Synonyms Anacin-3, P-Acetaminophenol, N-Acetyl-P-Aminophenol, Paracetamol, Phenaphen, Excedrine®, NAPA, Tempra®, Datril®, Panadol®, Tylenol®.
DELTA AMINOLEVULINIC ACID (ALA)
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
FOLIC ACID (FOLATES)
Clinical Significance/Clinical Use:: Determine the concentration of folate, a deficiency of folate can cause megaloblastic anemia.
Indications: N/A
Clinical Significance/Clinical Use:: Determine the concentration of folate, a deficiency of folate can cause megaloblastic anemia.
Indications: N/A
HYDROXYINDOLEACETIC ACID-(5-HIAA)
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
HOMOVANILLIC ACID
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
LACTIC ACID (LACTATE)
Indications: (See Blood Gases)
Indications: (See Blood Gases)
URIC ACID
Type of sample: Serum, plasma, urine, other body fluids.
Clinical significance/clinical use: Diagnosis and treatment of numerous renal and metabolic disorders.
Indications:N/A
Type of sample: Serum, plasma, urine, other body fluids.
Clinical significance/clinical use: Diagnosis and treatment of numerous renal and metabolic disorders.
Indications:N/A
VALPROIC ACID
Type of sample: Serum or plasma.
Indications:N/A
Type of sample: Serum or plasma.
Indications:N/A
ACYLCARNITINE
Indications: Must be well fed.
Indications: Must be well fed.
ACTH
Indications: Take sample between 7 – 10 am.
Indications: Take sample between 7 – 10 am.
TPMT (THIOPURINE METHILTRANSFERASE) ACTIVITY
Indications: Blood is collected prior to azathioprine (Imuran) or 6-mercaptopurine (6-MP, Purinethol) therapy for screening purposes. The extraction time is at the discretion of the doctor. Preferably the patient takes Monday or Wednesday before 9 am.
Indications: Blood is collected prior to azathioprine (Imuran) or 6-mercaptopurine (6-MP, Purinethol) therapy for screening purposes. The extraction time is at the discretion of the doctor. Preferably the patient takes Monday or Wednesday before 9 am.
ADALIMUMAB ANTI-DRUG ANTIBODY
Indications: No BIOTIN supplements in 48 hours, does not require fasting. (Inflammatory Bowel Disease).
Indications: No BIOTIN supplements in 48 hours, does not require fasting. (Inflammatory Bowel Disease).
ADALIMUMAB LEVELS
Indications: Sample collection before the next infusion of adalimumab. (Inflammatory Bowel Disease).
Indications: Sample collection before the next infusion of adalimumab. (Inflammatory Bowel Disease).
FEBRILE AGGLUTINATIONS
Indications: Serum.
Indications: Serum.
COLD AGGGLUTININS (CRYOAGGGLUTININS)
Type of sample: Serum.
Clinical Significance: For diagnosis of Mycoplasma pneumoniae infection.
Indications: N/A.
Type of sample: Serum.
Clinical Significance: For diagnosis of Mycoplasma pneumoniae infection.
Indications: N/A.
PLATELET AGGREGABILITY
Type of sample: Citrated plasma (4 light blue cap tubes).
Clinical Significance: Measure the functionality of the platelets.
Special Note:: the patient must suspend the following medications: Aspirin, Antihistamines, Ibuprofen, Gentamicin, Marijuana, Tricyclic Antidepressants and corticosteroids 7 days before sample collection.
Indications: There are prescription or over-the-counter medications that can interfere with aggregability; especially those that contain aspirin, if taken up to 10 days before blood collection. Similarly, the test can be affected by antihistamines, ibuprofen, gentamicin, marijuana, anti-inflammatories, cocaine, theophylline, tricyclic antidepressants, and corticosteroids. On the day of the test, avoid caffeine, smoking, and drinking alcohol. Avoid coumadin (oral anticoagulant) two weeks before the test and heparin one week before. Studies should not be performed soon after a high-fat meal, as chylomicrons may interfere with the measurement of platelet aggregation. Many "normal" components of the diet, including onions, garlic, peppers, and ginger, can also inhibit platelet aggregation. Indicate the consumption of these foods and spices, taking into account their effects when evaluating the results.
Type of sample: Citrated plasma (4 light blue cap tubes).
Clinical Significance: Measure the functionality of the platelets.
Special Note:: the patient must suspend the following medications: Aspirin, Antihistamines, Ibuprofen, Gentamicin, Marijuana, Tricyclic Antidepressants and corticosteroids 7 days before sample collection.
Indications: There are prescription or over-the-counter medications that can interfere with aggregability; especially those that contain aspirin, if taken up to 10 days before blood collection. Similarly, the test can be affected by antihistamines, ibuprofen, gentamicin, marijuana, anti-inflammatories, cocaine, theophylline, tricyclic antidepressants, and corticosteroids. On the day of the test, avoid caffeine, smoking, and drinking alcohol. Avoid coumadin (oral anticoagulant) two weeks before the test and heparin one week before. Studies should not be performed soon after a high-fat meal, as chylomicrons may interfere with the measurement of platelet aggregation. Many "normal" components of the diet, including onions, garlic, peppers, and ginger, can also inhibit platelet aggregation. Indicate the consumption of these foods and spices, taking into account their effects when evaluating the results.
ALANINE AMINO TRANSFERASE (ALT)
Type of sample: Serum or plasma
Clinical Significance: Diagnosis and treatment of liver and heart diseases.
Indications: N/A.
Type of sample: Serum or plasma
Clinical Significance: Diagnosis and treatment of liver and heart diseases.
Indications: N/A.
ALBUMIN
Type of sample: Serum or plasma.
Clinical Significance: Diagnosis and treatment of diseases affecting the liver or kidneys.
Type of sample: Serum or plasma.
Clinical Significance: Diagnosis and treatment of diseases affecting the liver or kidneys.
ETHYL ALCOHOL (ETHANOL)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
ALDOLASE
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
ALDOSTERONE
Indications: Patient must be seated for at least 1/2 hour before sampling with the patient upright. The sample must be taken between 8-10 am or between 4-6 pm.
Indications: Patient must be seated for at least 1/2 hour before sampling with the patient upright. The sample must be taken between 8-10 am or between 4-6 pm.
ALLERGIES (RAST IgE)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
ALPHA 1 – QUANTITATIVE ANTITRYPSIN AND PHENOTYPE
Indications: Fasting preferable.
Indications: Fasting preferable.
ALPHA FETO PROTEINS
Type of sample: Serum.
Clinical significance/clinical use:Diagnosis, prognosis and management of patients with testicular cancer.
Indications: N/A
Type of sample: Serum.
Clinical significance/clinical use:Diagnosis, prognosis and management of patients with testicular cancer.
Indications: N/A
AMYLASE
Type of sample: Serum, Plasma, Urine.
Clinical significance/clinical use:Diagnosis and treatment of pancreatitis
Indications: N/A
Type of sample: Serum, Plasma, Urine.
Clinical significance/clinical use:Diagnosis and treatment of pancreatitis
Indications: N/A
AMMONIUM
Type of sample:Plasma.
Clinical significance/clinical use: Diagnosis of hepatic encephalopathy and hepatic coma.
Note: Invalid procedure in neonate samples.
Type of sample:Plasma.
Clinical significance/clinical use: Diagnosis of hepatic encephalopathy and hepatic coma.
Note: Invalid procedure in neonate samples.
ANCA SCREEN
Type of sample: Serum or plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANDROSTENEDIONA
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
ANTI-CPC
Type of sample: Serum or plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTI CENTROMERE
Type of sample: Serum or plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTI HU
Indications: Preferably fast all night.
Indications: Preferably fast all night.
ANTI LA (SSB) / ANTI RO (SSA)
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTIPR3
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTI-RNP /Sm
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTI-ScL-70
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTI-SMITH
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
LUPUS ANTICOAGULANTS
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
ANTIBODY AGAINST GANGLIONAL ACETYLCHOLINE RECEPTOR (ALPHA 3)
alternative names: A3-AChR antibody, nAChR ganglionic neuronal antibody.
alternative names: A3-AChR antibody, nAChR ganglionic neuronal antibody.
ANTIGANGLOSIDE GQ1B ANTIBODIES (IGG)
Indications: Preferably fast all night.
Indications: Preferably fast all night.
ANTI-NUCLEAR ANTIBODIES (ANA)
Type of sample: Serum
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases specifically Lupus Erytomatosus (SLE) and patients with polymyositis, scleroderma and antiphospholipid syndrome.
Indications: N/A
Type of sample: Serum
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases specifically Lupus Erytomatosus (SLE) and patients with polymyositis, scleroderma and antiphospholipid syndrome.
Indications: N/A
ANTI-DNA
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
CARCINOEMBRYONIC ANTIGEN (CEA)
Type of sample: Serum or Plasma.
Clinical significance/clinical use: Prognosis and treatment of patients affected by cancer.
Indications: N/A
Type of sample: Serum or Plasma.
Clinical significance/clinical use: Prognosis and treatment of patients affected by cancer.
Indications: N/A
PROSTATE SPECIFIC ANTIGEN (Total PSA)
Type of sample: Serum.
Clinical significance/clinical use: Helps in the detection and treatment of prostate cancer.
Indications: N/A
Type of sample: Serum.
Clinical significance/clinical use: Helps in the detection and treatment of prostate cancer.
Indications: N/A
FREE PROSTATE SPECIFIC ANTIGEN (free PSA)
Type of sample: Serum.
Clinical significance/clinical use: Used to distinguish between prostate cancer and benign disease.
Indications: N/A
Type of sample: Serum.
Clinical significance/clinical use: Used to distinguish between prostate cancer and benign disease.
Indications: N/A
ANTI JO
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTI MPO
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
ANTITHROMBIN III
Type of sample: Citrated plasma (without hemolysis).
Type of sample: Citrated plasma (without hemolysis)
Volume/minimum sample quantity: 500uL
Clinical Significance.: It is an inhibitor of several coagulation factors. The difference is associated with hypercoagulation (increased risk of venous thrombosis). Concentrations may be decreased in liver disease, nephrotic syndrome, and other medical conditions.
Indications: N/A
Type of sample: Citrated plasma (without hemolysis).
Type of sample: Citrated plasma (without hemolysis)
Volume/minimum sample quantity: 500uL
Clinical Significance.: It is an inhibitor of several coagulation factors. The difference is associated with hypercoagulation (increased risk of venous thrombosis). Concentrations may be decreased in liver disease, nephrotic syndrome, and other medical conditions.
Indications: N/A
ARGININE VASOPRESSIN (AVP, ANTIDIURETIC HORMONE, ADH)
Indications: See Copeptin test.
Indications: See Copeptin test.
ASPARTATE AMINOTRANSFERASE (AST)
Type of sample: Serum or plasma.
Clinical significance/clinical use: Diagnosis and treatment of certain liver and/or heart diseases.
Indications: N/A
Type of sample: Serum or plasma.
Clinical significance/clinical use: Diagnosis and treatment of certain liver and/or heart diseases.
Indications: N/A
REDUCING SUGARS
Type of sample: Stool
Clinical significance/clinical use: Unabsorbed sugars are measured in feces as reducing substances and are considered as indicators of viral, infectious or indeterminate infections in diarrheal processes, especially in young children who drink breast milk.
Indications: N/A
Type of sample: Stool
Clinical significance/clinical use: Unabsorbed sugars are measured in feces as reducing substances and are considered as indicators of viral, infectious or indeterminate infections in diarrheal processes, especially in young children who drink breast milk.
Indications: N/A
B
BCR-ABL 1 GENE REARRANGEMENT, QUANTITATIVE, PCR
Note: Sampling only Monday or Wednesday before 9 am.
Note: Sampling only Monday or Wednesday before 9 am.
BETA 2 MICROGLOBULIN
Type of sample: Serum or plasma
Clinical significance/clinical use: For diagnosis of lymphoma, multiple myeloma, lupus
production increases.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: For diagnosis of lymphoma, multiple myeloma, lupus
production increases.
Indications: N/A
BETA GLOBIN
Note: Sampling only Monday or Wednesday before 9 am. Physician must include “Clinical indication” information.
Note: Sampling only Monday or Wednesday before 9 am. Physician must include “Clinical indication” information.
BILE, ACIDS (TOTAL AND FRACTIONATED)
Indications: Preferably fast all night.
Indications: Preferably fast all night.
DIRECT, INDIRECT AND TOTAL BILIRUBIN
Type of sample: Serum or plasma
Clinical significance/clinical use: Diagnosis and treatment of liver diseases, hemolytic, hematological and metabolic disorders.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: Diagnosis and treatment of liver diseases, hemolytic, hematological and metabolic disorders.
Indications: N/A
BRCA1, BRCA2 / BRCAVANTAGE COMPREHENSIVE EVALUATION
Indications:: Requires filling out a special cancer family history form.
Indications:: Requires filling out a special cancer family history form.
C
17-CETOSTEROIDS
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
C -COLLAGEN TERMINAL TELOPEPTIDE (CTX, BETA-CROSSLAPS)
Indications: Minimum 12 hours of fasting. Take samples between 8 – 10 am. If you take Biotin, you must stop it 8 hours before taking it and if you use large doses 72 hours before.
Indications: Minimum 12 hours of fasting. Take samples between 8 – 10 am. If you take Biotin, you must stop it 8 hours before taking it and if you use large doses 72 hours before.
C1Q COMPLEMENT, COMPONENT, ANTIGEN
alternative names: C1 inactivator, C1 Esterase functional.
alternative names: C1 inactivator, C1 Esterase functional.
C3 COMPLEMENT FRACTION
Type of sample: Serum
Clinical significance/clinical use: Diagnosis of immunological disorders, especially those associated with insufficiency of complement components.
Indications: N/A
Type of sample: Serum
Clinical significance/clinical use: Diagnosis of immunological disorders, especially those associated with insufficiency of complement components.
Indications: N/A
C4 COMPLEMENT FRACTION
Type of sample: Serum
Clinical significance/clinical use: Diagnosis of immunological disorders, especially those associated with insufficiency of complement components.
Indications: N/A
Type of sample: Serum
Clinical significance/clinical use: Diagnosis of immunological disorders, especially those associated with insufficiency of complement components.
Indications: N/A
AC 15.3
Type of sample: Serum or plasma
Clinical significance/clinical use: Treatment of stage 2 and 3 breast cancer.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: Treatment of stage 2 and 3 breast cancer.
Indications: N/A
AC 19.9
Type of sample: Serum or plasma
Clinical significance/clinical use: CA-19.9 levels are used to monitor response to gastric cancer treatment.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: CA-19.9 levels are used to monitor response to gastric cancer treatment.
Indications: N/A
AC27-29
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
AC 125
Type of sample: Serum, plasma
Clinical significance/clinical use: It is used as a follow-up to the treatment response of patients with ovarian cancer.
Indications: N/A
Type of sample: Serum, plasma
Clinical significance/clinical use: It is used as a follow-up to the treatment response of patients with ovarian cancer.
Indications: N/A
INTERLEUKIN 2 RECEPTOR ALPHA CHAIN (IL-2 RA/CD25)
Indications: Do not take Biotin supplements in 24 hours.
Indications: Do not take Biotin supplements in 24 hours.
TOTAL CALCIUM
Type of sample: Serum, plasma, urine.
Clinical significance/clinical use: Diagnosis and treatment of parathyroid diseases, various bone diseases, chronic kidney disease.
Indications: N/A
Type of sample: Serum, plasma, urine.
Clinical significance/clinical use: Diagnosis and treatment of parathyroid diseases, various bone diseases, chronic kidney disease.
Indications: N/A
CALCITONIN
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
CALCULATION (STONE)
Indications: Indicate the origin of the stone (renal, urethral, etc.).
Indications: Indicate the origin of the stone (renal, urethral, etc.).
URINARY STONE (ANALYSIS)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
Qualitative CALPROCTECTIN (includes Lactoferrin, FOB and Transferrin)
Methodology:: Qualitative immunochromatography
Clinical significance/clinical use: To determine severe gastroenteritis that is detected by vomiting and diarrhea.
Indications: N/A
Methodology:: Qualitative immunochromatography
Clinical significance/clinical use: To determine severe gastroenteritis that is detected by vomiting and diarrhea.
Indications: N/A
CALPROCTECTIN in Stool Quantitative
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
CARBAMAZEPINE (Tegretol)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
CARDIOLIPIN IGM / IGG
Type of sample: Serum, Plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma
Clinical significance/clinical use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
HIV VIRAL LOAD
Type of sample: Whole blood with EDTA or ACD
Clinical significance/clinical use: Measurement of blood plasma HIV RNA concentration or viral load by nucleic acid-based molecular diagnostic assays is the established gold standard for assessing the prognosis of HIV-positive patients and response to antiviral therapy.
Indications: N/A
Type of sample: Whole blood with EDTA or ACD
Clinical significance/clinical use: Measurement of blood plasma HIV RNA concentration or viral load by nucleic acid-based molecular diagnostic assays is the established gold standard for assessing the prognosis of HIV-positive patients and response to antiviral therapy.
Indications: N/A
BLOOD KARYOTYPE
Indications: Sampling only Monday or Wednesday before 9 am. Physician must include “Clinical indication” information.
Indications: Sampling only Monday or Wednesday before 9 am. Physician must include “Clinical indication” information.
KARYOTYPE: CHROMOSOMAL ANALYSIS, HEMATOLOGICAL NEOPLASM
Clinical Significance: May help detect common chromosomal abnormalities.
Note: Sampling only Monday or Wednesday before 9 am.
Indications: Physician must include “Clinical indication” information.
Clinical Significance: May help detect common chromosomal abnormalities.
Note: Sampling only Monday or Wednesday before 9 am.
Indications: Physician must include “Clinical indication” information.
CARNITINE
Indications: Patient must be well fed.
Indications: Patient must be well fed.
CAROTENE (BETA CAROTENE)
Indications: Overnight fasting is required.
Indications: Overnight fasting is required.
BLOOD CATECHOLAMINES
Indications: Fasting overnight is preferable. You should avoid alcohol, coffee, tea, tobacco, and strenuous exercise before sample collection. The patient must be relaxed in a supine or upright position before blood is drawn. States of anxiety and stress can cause fluctuations in catecholamine levels.
Note: Includes epinephrine, norepinephrine, dopamine, and total catecholamines (calculated).
Indications: Fasting overnight is preferable. You should avoid alcohol, coffee, tea, tobacco, and strenuous exercise before sample collection. The patient must be relaxed in a supine or upright position before blood is drawn. States of anxiety and stress can cause fluctuations in catecholamine levels.
Note: Includes epinephrine, norepinephrine, dopamine, and total catecholamines (calculated).
URINE FRACTIONATED CATECHOLAMINES
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
CD4/CD8
Indications: Sample must be collected on Monday or Wednesday before 9 am due to the stability of the sample.
Indications: Sample must be collected on Monday or Wednesday before 9 am due to the stability of the sample.
CERULOPLASMIN
Indications: Fasting overnight preferable.
Indications: Fasting overnight preferable.
CHLAMYDIA TRACHOMATIS – PCR (Includes Neisseria gonorrhoeae)
Type of sample: Urine, cervical sample, endocervical
Clinical significance/clinical use: Most common bacterial sexual infection. It can lead to an ectopic pregnancy, pelvic inflammatory disease and infertility.
Indications: N/A
Type of sample: Urine, cervical sample, endocervical
Clinical significance/clinical use: Most common bacterial sexual infection. It can lead to an ectopic pregnancy, pelvic inflammatory disease and infertility.
Indications: N/A
Cyclosporine
Indications: Take sample 12 hours after the last dose.
Indications: Take sample 12 hours after the last dose.
CYTOMEGALOVIRUSES (IGG, IGM)
Type of sample: Serum
Clinical significance/clinical use: Infections with this virus can cause birth defects in newborns who may be infected.
Indications: N/A
Type of sample: Serum
Clinical significance/clinical use: Infections with this virus can cause birth defects in newborns who may be infected.
Indications: N/A
FLOW CYTOMETRY (CD)
Indications: Consult the laboratory.
Indications: Consult the laboratory.
CITRATE
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
CLONAZEPAM
Indications: Sample taken just before ingesting the next dose.
Indications: Sample taken just before ingesting the next dose.
CHLORINE
Type of sample: Serum, plasma, urine, CSF.
Clinical significance/clinical use: Diagnosis and treatment of electrolyte and metabolic disorders.
Indications: N/A
Type of sample: Serum, plasma, urine, CSF.
Clinical significance/clinical use: Diagnosis and treatment of electrolyte and metabolic disorders.
Indications: N/A
CLOSTRIDIUM DIFFICILE PCR
Type of sample: Stools (liquid or soft)
Clinical significance/clinical use: To detect this spore-forming Gram-positive anaerobic bacillus whose infection causes from diarrhea to severe and potentially fatal pseudomembranous colitis, using B toxins by the PCR method that has a high sensitivity compared to other tests.
Indications: The stool sample must be liquid.
Type of sample: Stools (liquid or soft)
Clinical significance/clinical use: To detect this spore-forming Gram-positive anaerobic bacillus whose infection causes from diarrhea to severe and potentially fatal pseudomembranous colitis, using B toxins by the PCR method that has a high sensitivity compared to other tests.
Indications: The stool sample must be liquid.
clozapine
Note: Includes Clozapine and Norclozapine.
Note: Includes Clozapine and Norclozapine.
COBALT
Indications: Do not take mineral supplements or Vitamin B for 3 days. The sample must be taken only on Monday and Wednesday before 9 am.
Indications: Do not take mineral supplements or Vitamin B for 3 days. The sample must be taken only on Monday and Wednesday before 9 am.
COCAINE
Type of sample: Random urine
Clinical significance/clinical use: To monitor drugs of abuse
Indications: N/A
Type of sample: Random urine
Clinical significance/clinical use: To monitor drugs of abuse
Indications: N/A
HIGH DENSITY CHOLESTEROL (HDL)
Type of sample: Serum, plasma
Clinical significance/clinical use: Low values risk of coronary disease.
Indications: N/A
Type of sample: Serum, plasma
Clinical significance/clinical use: Low values risk of coronary disease.
Indications: N/A
LOW DENSITY CHOLESTEROL (LDL- calculated)
Type of sample: Serum, plasma
Clinical significance/clinical use: If it is elevated, it may indicate risk of coronary disease.
Note: Can only be reported if triglycerides are less than 400mg/dL.
Indications: N/A
Type of sample: Serum, plasma
Clinical significance/clinical use: If it is elevated, it may indicate risk of coronary disease.
Note: Can only be reported if triglycerides are less than 400mg/dL.
Indications: N/A
TOTAL CHOLESTEROL
Type of sample: Serum, plasma
Clinical significance/clinical use: Diagnosis and treatment of atherosclerotic coronary disease.
Indications: N/A
Type of sample: Serum, plasma
Clinical significance/clinical use: Diagnosis and treatment of atherosclerotic coronary disease.
Indications: N/A
CHOLINESTERASE
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
COMPLEMENT, TOTAL (CH50)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
COPEPTIN
Note: This test replaces the arginine vasopressin test.
Note: This test replaces the arginine vasopressin test.
CORTISOL
Type of sample: Serum, plasma, urine
Clinical significance/clinical use: Diagnosis and treatment of adrenal disorders.
Indications: N/A
Type of sample: Serum, plasma, urine
Clinical significance/clinical use: Diagnosis and treatment of adrenal disorders.
Indications: N/A
SALIVA CORTISOL
Indications: Requires a special sample kit. Pre-schedule with the laboratory.
Indications: Requires a special sample kit. Pre-schedule with the laboratory.
FREE CORTISOL
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
COVID (PCR)
Type of sample: Nasopharyngeal swab
Clinical significance/clinical use: Diagnosis of Covid 19.
Indications: It is required to fill out the form.
Type of sample: Nasopharyngeal swab
Clinical significance/clinical use: Diagnosis of Covid 19.
Indications: It is required to fill out the form.
COVID ANTIBODY IGA/IGM
Type of sample: Serum or plasma
Clinical significance/clinical use: Seroprevalence of Covid-19 disease
Indications: It is required to fill out the form.
Type of sample: Serum or plasma
Clinical significance/clinical use: Seroprevalence of Covid-19 disease
Indications: It is required to fill out the form.
COVID ANTIBODY IGG (Spike)
Type of sample: Serum
Clinical significance/clinical use: Seroprevalence of Covid-19 disease
Indications: N/A
Type of sample: Serum
Clinical significance/clinical use: Seroprevalence of Covid-19 disease
Indications: N/A
COVID ANTIBODY RAPID TEST (only available in Coronado)
Type of sample: Serum, plasma
Clinical significance/clinical use: Seroprevalence of Covid-19 disease.
Indications: N/A
Type of sample: Serum, plasma
Clinical significance/clinical use: Seroprevalence of Covid-19 disease.
Indications: N/A
COVID ANTIGEN
Type of sample: Nasopharyngeal swab
Clinical significance/clinical use: Diagnosis of Covid 19.
Indications: N/A
Type of sample: Nasopharyngeal swab
Clinical significance/clinical use: Diagnosis of Covid 19.
Indications: N/A
CREATIN KINASE (TOTAL CPK)
Type of sample: Serum or plasma
Clinical significance/clinical use: Diagnosis and treatment of myocardial infarctions.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: Diagnosis and treatment of myocardial infarctions.
Indications: N/A
CREATIN KINASE MB (CK-MB)
Type of sample: Serum or plasma
Clinical significance/clinical use: To evaluate myocardial disease.
Indications: N/A
Type of sample: Serum or plasma
Clinical significance/clinical use: To evaluate myocardial disease.
Indications: N/A
CREATININE
Type of sample: Serum, plasma, urine.
Clinical significance/clinical use: Diagnosis and treatment of kidney diseases.
Indications: N/A
Type of sample: Serum, plasma, urine.
Clinical significance/clinical use: Diagnosis and treatment of kidney diseases.
Indications: N/A
CREATININE CLEARANCE
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
URINE CREATININE
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
GROWTH HORMONE (HGh)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
CHROME
Indications: Do not take mineral supplements or Vitamin B for 3 days.
Indications: Do not take mineral supplements or Vitamin B for 3 days.
SPUTUM CULTURE
Indications: First thing in the morning, rinse your mouth with water. If you wear dentures (veneers), remove them first. Open the lid of the sterile package and expectorate directly. When you finish collecting the sample, close the container tightly with the lid to prevent spillage. Write your name, ID / passport and date of collection on the container (not on the lid). Immediately transport the sample to the laboratory where the suitability of the sample for culture will be assessed. NOTES: Small amounts of clear material usually represent saliva not suitable for culture (Collect new sample). Collect only one sample per container. Do not collect several samples in the same container. When coughing, be sure to pluck deeply so the sample is thick (phlegm) and not saliva. In case the laboratory finds that the sample is not adequate, the culture will not be performed, and a new sample will be requested. Take the sample in an open place (with ventilation) not in the bathroom. Note: It is required to fill out the Microbiology network form
Indications: First thing in the morning, rinse your mouth with water. If you wear dentures (veneers), remove them first. Open the lid of the sterile package and expectorate directly. When you finish collecting the sample, close the container tightly with the lid to prevent spillage. Write your name, ID / passport and date of collection on the container (not on the lid). Immediately transport the sample to the laboratory where the suitability of the sample for culture will be assessed. NOTES: Small amounts of clear material usually represent saliva not suitable for culture (Collect new sample). Collect only one sample per container. Do not collect several samples in the same container. When coughing, be sure to pluck deeply so the sample is thick (phlegm) and not saliva. In case the laboratory finds that the sample is not adequate, the culture will not be performed, and a new sample will be requested. Take the sample in an open place (with ventilation) not in the bathroom. Note: It is required to fill out the Microbiology network form
STOOL CULTURE (COPROCULTURE)
Type of sample: Stool
Clinical significance/clinical use: To identify Enteropathogenic organisms which are the bacteria that cause diarrhoea.
Indications: N/A
Type of sample: Stool
Clinical significance/clinical use: To identify Enteropathogenic organisms which are the bacteria that cause diarrhoea.
Indications: N/A
MUSHROOM CULTURE
Type of sample: Scraping of skin, hair, nails, direct wound swabs, sputum, bronchial washings, CSF, body fluids.
Clinical significance/clinical use: Fungi can infect cerebrospinal fluid, other fluids, and tissues. These infections occur in immunosuppressed patients. Early diagnosis and effective treatment can reduce sequelae.
Indications: N/A
Type of sample: Scraping of skin, hair, nails, direct wound swabs, sputum, bronchial washings, CSF, body fluids.
Clinical significance/clinical use: Fungi can infect cerebrospinal fluid, other fluids, and tissues. These infections occur in immunosuppressed patients. Early diagnosis and effective treatment can reduce sequelae.
Indications: N/A
CEREBROSPINAL FLUID (CSF) CULTURE
Type of sample: CSF, collect 2mL in a sterile bottle (tube #2).
Clinical significance/clinical use: Early diagnosis and effective treatment can reduce sequelae. Useful in the diagnosis of meningitis.
Indications: N/A
Type of sample: CSF, collect 2mL in a sterile bottle (tube #2).
Clinical significance/clinical use: Early diagnosis and effective treatment can reduce sequelae. Useful in the diagnosis of meningitis.
Indications: N/A
URINE CULTURE (URINE CULTURE)
Type of sample: Preferably morning urine, half stream after aseptic cleansing.
Clinical significance/clinical use: Useful in the diagnosis and treatment of urinary tract infections.
Note: Colony count, identification of the organism and Antibiogram.
Indications: It is preferable that the sample is collected in the laboratory. Use a sterile container for urine collection. Thoroughly clean the genital area with soap and water. Rinse with plenty of water to remove soap. Be careful not to touch the edge or inside of the container to avoid contaminating it. Urinate into the bottle, discarding the first stream of urine. Close the container tightly and deliver it to the laboratory. Be sure to label the container with full name, ID/passport, date and time of collection. The best urine sample is first thing in the morning when you get up.
Type of sample: Preferably morning urine, half stream after aseptic cleansing.
Clinical significance/clinical use: Useful in the diagnosis and treatment of urinary tract infections.
Note: Colony count, identification of the organism and Antibiogram.
Indications: It is preferable that the sample is collected in the laboratory. Use a sterile container for urine collection. Thoroughly clean the genital area with soap and water. Rinse with plenty of water to remove soap. Be careful not to touch the edge or inside of the container to avoid contaminating it. Urinate into the bottle, discarding the first stream of urine. Close the container tightly and deliver it to the laboratory. Be sure to label the container with full name, ID/passport, date and time of collection. The best urine sample is first thing in the morning when you get up.
BLOOD CULTURE (BLOOD CULTURE)
Type of sample: whole blood
Clinical significance/clinical use: Culture can identify aerobic and anaerobic organisms in blood. Mixed bacterial infections are common and can involve these two types of bacteria. When an organism is identified, an antibiotic susceptibility is made to guide selection of the appropriate treatment.
Type of sample: whole blood
Clinical significance/clinical use: Culture can identify aerobic and anaerobic organisms in blood. Mixed bacterial infections are common and can involve these two types of bacteria. When an organism is identified, an antibiotic susceptibility is made to guide selection of the appropriate treatment.
CULTURE OF SECRETION (PHARYNGEAL, NASAL, OTIC, OCULAR, VAGINAL, SEMEN)
Stability: Room temperature up to 24 hours
Clinical significance/clinical use: To detect infections by numerous bacteria. When the bacterium is identified, an antibiogram or sensitivity to antibiotics is run to guide the selection of antibiotic treatment.
Indications: N/A
Stability: Room temperature up to 24 hours
Clinical significance/clinical use: To detect infections by numerous bacteria. When the bacterium is identified, an antibiogram or sensitivity to antibiotics is run to guide the selection of antibiotic treatment.
Indications: N/A
CULTURE FOR ACID ALCOHOL FAST BACILLUS (BAAR)
Type of sample: sputum, bronchial washings, CSF
Clinical significance/clinical use: Tuberculosis is a chronic, granule-matous disease caused by Mycobacterium tuberculosis. Its identification is needed and, if necessary, the sensitivity of the microorganism to start treatment.
Indications: It is required to fill out the form.
Type of sample: sputum, bronchial washings, CSF
Clinical significance/clinical use: Tuberculosis is a chronic, granule-matous disease caused by Mycobacterium tuberculosis. Its identification is needed and, if necessary, the sensitivity of the microorganism to start treatment.
Indications: It is required to fill out the form.
D
DEHYDROEPIANDROSTERONE-SULFATE (DHEA-SO4)
Type of sample: Serum, plasma
Clinical significance/clinical use: It is used in the differential diagnosis of Cushing's syndrome, evaluates adrenocortical diseases. Elevated in patients with polycystic ovaries.
Indications: N/A
Type of sample: Serum, plasma
Clinical significance/clinical use: It is used in the differential diagnosis of Cushing's syndrome, evaluates adrenocortical diseases. Elevated in patients with polycystic ovaries.
Indications: N/A
LACTIC DEHYDROGENASE (LDH)
Type of sample: Serum, plasma, CSF
Clinical significance/clinical use: Diagnosis and treatment of liver disease, heart disease, and kidney and lung tumors.
Indications: N/A
Type of sample: Serum, plasma, CSF
Clinical significance/clinical use: Diagnosis and treatment of liver disease, heart disease, and kidney and lung tumors.
Indications: N/A
DENGUE (Detection of NS1 Antigen in early phase)
Type of sample: Serum.
clinical significance: The NSI antigen is detected in the serum in the early stages, day 1-9 of the onset of dengue symptoms.
Indications: N/A
Type of sample: Serum.
clinical significance: The NSI antigen is detected in the serum in the early stages, day 1-9 of the onset of dengue symptoms.
Indications: N/A
DENGUE IgM ANTIBODY
Type of sample: Serum.
clinical significance: It is used as an aid with patients with conscious clinical symptoms with Dengue fever.
Indications: N/A
Type of sample: Serum.
clinical significance: It is used as an aid with patients with conscious clinical symptoms with Dengue fever.
Indications: N/A
DENGUE ANTIBODY IgG
Type of sample: Serum.
clinical significance: It is used as an aid with patients with conscious clinical symptoms with Dengue fever.
Indications: N/A
Type of sample: Serum.
clinical significance: It is used as an aid with patients with conscious clinical symptoms with Dengue fever.
Indications: N/A
DIGOXIN
Type of sample: Serum or plasma
clinical significance: Diagnosis and treatment of digoxin overdose and for concentration determination as an aid in determining appropriate treatment.
Indications: N/A
Type of sample: Serum or plasma
clinical significance: Diagnosis and treatment of digoxin overdose and for concentration determination as an aid in determining appropriate treatment.
Indications: N/A
DIMEROS –D
Type of sample: Non-hemolyzed citrated plasma
clinical significance: D-dimers is one of the by-products of the activation of the fibrinolytic system. To assess fibrinolytic activation and intravascular thrombosis. D-dimers are of particular value in excluding the diagnosis of thromboembolism among patients who are at high risk.
Indications: N/A
Type of sample: Non-hemolyzed citrated plasma
clinical significance: D-dimers is one of the by-products of the activation of the fibrinolytic system. To assess fibrinolytic activation and intravascular thrombosis. D-dimers are of particular value in excluding the diagnosis of thromboembolism among patients who are at high risk.
Indications: N/A
CARBON DIOXIDE (CO2)
Type of sample: Serum or plasma
clinical significance: Diagnosis and treatment of numerous potentially serious disorders related to changes in acid-base balance.
Indications: N/A
Type of sample: Serum or plasma
clinical significance: Diagnosis and treatment of numerous potentially serious disorders related to changes in acid-base balance.
Indications: N/A
DOPAMINE
Indications: It is preferable that the patient suspend medications 3 days before collecting the sample but should consult the doctor (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, alpha and beta blockers may or may not interfere). Patient should avoid alcohol, coffee, tea, tobacco, and strenuous exercise before collecting sample.
Indications: It is preferable that the patient suspend medications 3 days before collecting the sample but should consult the doctor (diuretics, angiotensin-converting enzyme inhibitors, calcium channel blockers, alpha and beta blockers may or may not interfere). Patient should avoid alcohol, coffee, tea, tobacco, and strenuous exercise before collecting sample.
PLASMA DOPAMINE
Indications: Patients should be relaxed in a supine or upright position before drawing blood. States of anxiety and stress can cause fluctuations in catecholamine levels. The patient should avoid alcohol, coffee, tea, tobacco, and strenuous exercise prior to collection. Overnight fasting is preferred.
Indications: Patients should be relaxed in a supine or upright position before drawing blood. States of anxiety and stress can cause fluctuations in catecholamine levels. The patient should avoid alcohol, coffee, tea, tobacco, and strenuous exercise prior to collection. Overnight fasting is preferred.
E
EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION (LIQUID BIOPSY – LUNG) – NSCLC
Indications: Sample must be taken Monday or Wednesday before 9 am.
Indications: Sample must be taken Monday or Wednesday before 9 am.
FECAL PANCREATIC ELASTASE
Indications: Collect stool sample (undiluted) in a clean, dry, spill-proof container.
Indications: Collect stool sample (undiluted) in a clean, dry, spill-proof container.
HEMOGLOBIN ELECTROPHORESIS
Type of sample: Whole blood.
clinical significance: With this test a preliminary identification of hemoglobinopathies and thalassemias is performed.
Indications: N/A
Type of sample: Whole blood.
clinical significance: With this test a preliminary identification of hemoglobinopathies and thalassemias is performed.
Indications: N/A
PROTEIN ELECTROPHORESIS
Type of sample: Serum.
clinical significance:
Indications: N/A
Type of sample: Serum.
clinical significance:
Indications: N/A
PREGNANCY QUALITATIVE TEST
Type of sample: Serum, urine.
clinical significance: To detect pregnancy.
Indications: N/A
Type of sample: Serum, urine.
clinical significance: To detect pregnancy.
Indications: N/A
PREGNANCY QUANTITATIVE TEST (BHCG)
Type of sample: Serum or plasma.
clinical significance: In pregnancy, the hormone can also be elevated in cases of testicular tumors, ovarian tumors.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: In pregnancy, the hormone can also be elevated in cases of testicular tumors, ovarian tumors.
Indications: N/A
ENA (SS-A, SS-B, SMITH, RNP)
Type of sample: Serum, Plasma.
Clinical Significance/Clinical Use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical Significance/Clinical Use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
EOSINOPHILS IN NASAL MUCUS
Type of sample: Nasal secretion in sheet.
clinical significance: Eosinophilia is found in patients with parasitic infections, asthma, some drug reactions.
Indications: N/A
Type of sample: Nasal secretion in sheet.
clinical significance: Eosinophilia is found in patients with parasitic infections, asthma, some drug reactions.
Indications: N/A
EPSTEIN BARR VIRUS: NUCLEAR ANTIGEN IgG ANTIBODIES (EBNA)
Type of sample: Serum.
clinical significance: These antibodies appear in infectious mononucleosis, lymphoproliferative disorders including tumors.
Indications: N/A
Type of sample: Serum.
clinical significance: These antibodies appear in infectious mononucleosis, lymphoproliferative disorders including tumors.
Indications: N/A
EPSTEIN BARR VIRUS: VCA CAPSIDE ANTIGEN IgG, IgM
Type of sample: Serum.
clinical significance: Infectious mononucleosis, lymphoproliferative disorders including tumors.
Indications: N/A
Type of sample: Serum.
clinical significance: Infectious mononucleosis, lymphoproliferative disorders including tumors.
Indications: N/A
ERYTHROPOIETIN
Indications: Due to diurnal variation, it is recommended that samples be taken between 7:30 am and noon.
Indications: Due to diurnal variation, it is recommended that samples be taken between 7:30 am and noon.
COMPLETE SPERMOGRAM
Type of sample: Semen.
clinical significance: Infertility.
Note: Abstinence from 4 to 6 days; obtaining by masturbation or seminal collector; the sample should be collected if possible in the laboratory.
Indications: You must abstain from sexual intercourse for a minimum of 2 days up to a maximum of 7 days. Wash your hands and urinate before collecting the sample. Collect the sample by masturbation and deposit it in the sterile container provided. Do not lose any part of ejaculate. If you lose part of the ejaculate or spill part of the sample over the entire first part, it cannot be analyzed. Label the container with the following information: Name, ID, date and time of collection. Deliver the sample to the laboratory in less than 30 minutes after collecting the sample. Avoid sudden temperature changes in the semen sample. If you have a sperm culture together with the spermogram, it can be done from the SAME SAMPLE. The spermogram test is only done on Thursday and must be received before 10:00 am.
Type of sample: Semen.
clinical significance: Infertility.
Note: Abstinence from 4 to 6 days; obtaining by masturbation or seminal collector; the sample should be collected if possible in the laboratory.
Indications: You must abstain from sexual intercourse for a minimum of 2 days up to a maximum of 7 days. Wash your hands and urinate before collecting the sample. Collect the sample by masturbation and deposit it in the sterile container provided. Do not lose any part of ejaculate. If you lose part of the ejaculate or spill part of the sample over the entire first part, it cannot be analyzed. Label the container with the following information: Name, ID, date and time of collection. Deliver the sample to the laboratory in less than 30 minutes after collecting the sample. Avoid sudden temperature changes in the semen sample. If you have a sperm culture together with the spermogram, it can be done from the SAME SAMPLE. The spermogram test is only done on Thursday and must be received before 10:00 am.
ESTRADIOL
Type of sample: Serum or plasma.
clinical significance: Estradiol is the estrogenic hormone secreted by the ovaries.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: Estradiol is the estrogenic hormone secreted by the ovaries.
Indications: N/A
F
INTRINSIC FACTOR (ANTIBODY)
Indications: Samples should not be taken from patients who have received vitamin B12 injection therapy in the past week.
Indications: Samples should not be taken from patients who have received vitamin B12 injection therapy in the past week.
SEMI-QUANTITATIVE RHEUMATOID FACTOR
Type of sample: Serum.
clinical significance: Rheumatoid arthritis. Patients with Sjören's Syndrome and Lupus may also be Rheumatoid Factor positive.
Indications: N/A
Type of sample: Serum.
clinical significance: Rheumatoid arthritis. Patients with Sjören's Syndrome and Lupus may also be Rheumatoid Factor positive.
Indications: N/A
FACTOR V LEIDEN AND FACTOR II (Prothrombin)
Type of sample: EDTA whole blood or Citrated whole blood.
clinical significance: Provides results for Factor II and Factor V Leiden mutations as an aid in diagnosis in individuals suspected of having thrombophilia.
Indications: N/A
Type of sample: EDTA whole blood or Citrated whole blood.
clinical significance: Provides results for Factor II and Factor V Leiden mutations as an aid in diagnosis in individuals suspected of having thrombophilia.
Indications: N/A
VON WILLEBRAND FACTOR
Type of sample: Citrated plasma (not hemolyzed).
clinical significance: Due to its role in blood adhesion and aggregation, Von Willebrand Factor plays an important role both in primary hemostasis, in the formation of the hemostatic plug, and in the coagulation process by stabilizing factor VIII.
Indications: N/A
Type of sample: Citrated plasma (not hemolyzed).
clinical significance: Due to its role in blood adhesion and aggregation, Von Willebrand Factor plays an important role both in primary hemostasis, in the formation of the hemostatic plug, and in the coagulation process by stabilizing factor VIII.
Indications: N/A
FACTORIZATION (V, VII, VIII, IX, X)
Type of sample: Citrated plasma.
clinical significance: Hemophilia, coagulation disorders in elevated Partial Thromboplastin Time.
Indications: N/A
Type of sample: Citrated plasma.
clinical significance: Hemophilia, coagulation disorders in elevated Partial Thromboplastin Time.
Indications: N/A
PHENYLKETONURIA (PKU)
Type of sample: Total capillary blood, heel (card).
clinical significance: Detects the deficiency in the enzyme that breaks down the amino acid phenylalanine and if an increase in T3 and T4 occurs together with phenylalanine it can cause brain damage.
Indications: Capillary blood sample.
Type of sample: Total capillary blood, heel (card).
clinical significance: Detects the deficiency in the enzyme that breaks down the amino acid phenylalanine and if an increase in T3 and T4 occurs together with phenylalanine it can cause brain damage.
Indications: Capillary blood sample.
PHENYTOIN (Dilantin)
Type of sample: Serum or plasma.
clinical significance: Measurement of anticonvulsant drugs. Monitoring of levels to ensure appropriate therapy.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: Measurement of anticonvulsant drugs. Monitoring of levels to ensure appropriate therapy.
Indications: N/A
PHENOBARBITAL
Type of sample: Serum, plasma.
clinical significance: It is an anticonvulsant and hypnotic calming drug. Therapeutic monitoring of the drug is useful to reduce doses and avoid toxicity.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: It is an anticonvulsant and hypnotic calming drug. Therapeutic monitoring of the drug is useful to reduce doses and avoid toxicity.
Indications: N/A
FERRITIN
Type of sample: Serum, plasma.
clinical significance: Diagnosis of iron deficiency anemia.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Diagnosis of iron deficiency anemia.
Indications: N/A
FGF-23 (FIBROBLAST GROWTH FACTOR 23)
Indications: It is preferable to take a sample on an empty stomach.
Indications: It is preferable to take a sample on an empty stomach.
FIBRINOGEN
Type of sample: Citrated plasma.
clinical significance: Low fibrinogen levels are associated with bleeding secondary to liver disease or disseminated intravascular coagulation (DIC).
Indications: N/A
Type of sample: Citrated plasma.
clinical significance: Low fibrinogen levels are associated with bleeding secondary to liver disease or disseminated intravascular coagulation (DIC).
Indications: N/A
FIBRINOGEN, DEGRADATION PRODUCTS (PDF)
Type of sample: Serum.
clinical significance: Elevated when the coagulation and fibrinolytic systems are activated.
Indications: N/A
Type of sample: Serum.
clinical significance: Elevated when the coagulation and fibrinolytic systems are activated.
Indications: N/A
CYSTIC FIBROSIS, SCREENING FOR MUTATION
Indications: It is required to detail the ethnicity of the patient: for example: Caucasian, Chinese, Jewish, etc.
Indications: It is required to detail the ethnicity of the patient: for example: Caucasian, Chinese, Jewish, etc.
fish
Indications: Consult the laboratory.
Indications: Consult the laboratory.
FIT TEST
Type of sample: Stool.
Clinical Significance/ Clinical Use: Presumptive diagnosis of possible gastrointestinal bleeding and inflammation caused by colorectal cancer.
Indications: N/A
Type of sample: Stool.
Clinical Significance/ Clinical Use: Presumptive diagnosis of possible gastrointestinal bleeding and inflammation caused by colorectal cancer.
Indications: N/A
FOLLICLE STIMULATING HORMONE (FSH)
Type of sample: Serum, plasma.
Clinical Significance/ Clinical Use: Useful in the evaluation of infertility and ovulation, especially when the study is combined with other evaluations of others.
Indications: N/A
Type of sample: Serum, plasma.
Clinical Significance/ Clinical Use: Useful in the evaluation of infertility and ovulation, especially when the study is combined with other evaluations of others.
Indications: N/A
ALKALINE PHOSPHATASE
Type of sample: Serum, plasma.
clinical significance: Increased concentrations are seen in patients with biliary obstruction.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Increased concentrations are seen in patients with biliary obstruction.
Indications: N/A
MATCH
Type of sample: Serum, plasma, urine.
clinical significance: Found in bone and muscle, affects kidney function.
Indications: N/A
Type of sample: Serum, plasma, urine.
clinical significance: Found in bone and muscle, affects kidney function.
Indications: N/A
G
G6PDH
Indications: Sampling Monday or Wednesday before 9 am for sample stability.
Indications: Sampling Monday or Wednesday before 9 am for sample stability.
GABAPENTIN
Indications: Sample taken 2 hours after the last dose. Alternative name Neurotin, Neurontin.
Indications: Sample taken 2 hours after the last dose. Alternative name Neurotin, Neurontin.
GALACTOSE
Type of sample: Total capillary blood, heel (card).
clinical significance: Galactose is an enzyme involved in the breakdown of milk sugars.
Indications: N/A
Type of sample: Total capillary blood, heel (card).
clinical significance: Galactose is an enzyme involved in the breakdown of milk sugars.
Indications: N/A
GAMMA GLUTAMY TRANSPEPTIDASE (GGT)
Type of sample: Serum, plasma.
clinical significance: Diagnosis and treatment of liver diseases.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Diagnosis and treatment of liver diseases.
Indications: N/A
GASES (pH, pCO2, pO2, HCO3, % Saturation 0.2, Base Excess)
Type of sample: Whole blood (arterial, venous).
clinical significance: Determination of acid-base status, monitoring and efficiency of the lungs.
Indications: N/A
Type of sample: Whole blood (arterial, venous).
clinical significance: Determination of acid-base status, monitoring and efficiency of the lungs.
Indications: N/A
GASTRIN
Indications: Fasting for 12 hours. If you take biotin, the sample should be 8 hours after the last shot and if you take large doses, 72 hours after the last shot.
Indications: Fasting for 12 hours. If you take biotin, the sample should be 8 hours after the last shot and if you take large doses, 72 hours after the last shot.
GIARDIA /CRYPTOSPORIDIUM (Antigen)
Type of sample: Stool.
Clinical Significance / Clinical Use: For the diagnosis and treatment of Giardia and Cryptosporidium infections in feces.
Indications: N/A
Type of sample: Stool.
Clinical Significance / Clinical Use: For the diagnosis and treatment of Giardia and Cryptosporidium infections in feces.
Indications: N/A
GLIADIN IGA, IGG
Type of sample: Serum, Plasma.
Clinical Significance / Clinical Use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
Type of sample: Serum, Plasma.
Clinical Significance / Clinical Use: Useful for the diagnosis of autoimmune diseases.
Indications: N/A
GLUCAGON
Indications: Fasting is required.
Indications: Fasting is required.
GLUCOSE
Type of sample: Serum, plasma, urine, CSF.
Clinical Significance / Clinical Use: Glucose in CSF: suggests meningitis and any other neurological disorder. Serum glucose is useful in the detection and management of diabetes.
Indications: Fasting is required.
Type of sample: Serum, plasma, urine, CSF.
Clinical Significance / Clinical Use: Glucose in CSF: suggests meningitis and any other neurological disorder. Serum glucose is useful in the detection and management of diabetes.
Indications: Fasting is required.
GLUCOSE 6 PHOSPHATE DEHYDROGENASE
Type of sample: Total capillary blood, heel (card).
clinical significance: G6PD is the most common enzyme deficiency in the world.
Indications: N/A
Type of sample: Total capillary blood, heel (card).
clinical significance: G6PD is the most common enzyme deficiency in the world.
Indications: N/A
QUANTITATIVE HUMAN CHORIONIC GONADOTROPIN (BHCG)
Indications: (See Pregnancy quantitative test)
Indications: (See Pregnancy quantitative test)
GONADOTROPIN RELEASING HORMONE (GN-RH)
Indications: Patient should not be on any hormonal treatment for 2 days (48 hours))
Indications: Patient should not be on any hormonal treatment for 2 days (48 hours))
THICK DROP (Malaria plaque)
Type of sample: Whole blood (EDTA)
clinical significance: To diagnose Malaria.
Indications: N/A
Type of sample: Whole blood (EDTA)
clinical significance: To diagnose Malaria.
Indications: N/A
H
17-HYDROCORTICOSTEROIDS
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
HAPTOGLOBIN
Indications: Preferably fast overnight.
Indications: Preferably fast overnight.
HBeAG (Hepatitis B e Antigen)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
PARASITES AND AMOEBA FAECES
Type of sample: Stool.
clinical significance: Helps in the diagnosis of an intestinal parasite infection.
Indications: Collect the stool sample directly in a clean and dry container (do not collect the sample that has fallen into the toilet water). Take a small part of the sample (approximately one teaspoon) and place it in the container. Use the plastic container, which should have a wide mouth, with a screw cap. Refrain from using containers found in your home such as sauce containers, soap boxes, etc., no matter how clean they are. Do not contaminate the stool sample with urine. If you collect the sample at home, bring it to the laboratory as soon as possible for analysis. If the sample is liquid, carry it during the first 30 minutes of collection. If it is semi-liquid during the first hour of collection. If it is solid, you can take it within 2 hours of collection. Be sure to label the container with name, ID, date and time of collection
Type of sample: Stool.
clinical significance: Helps in the diagnosis of an intestinal parasite infection.
Indications: Collect the stool sample directly in a clean and dry container (do not collect the sample that has fallen into the toilet water). Take a small part of the sample (approximately one teaspoon) and place it in the container. Use the plastic container, which should have a wide mouth, with a screw cap. Refrain from using containers found in your home such as sauce containers, soap boxes, etc., no matter how clean they are. Do not contaminate the stool sample with urine. If you collect the sample at home, bring it to the laboratory as soon as possible for analysis. If the sample is liquid, carry it during the first 30 minutes of collection. If it is semi-liquid during the first hour of collection. If it is solid, you can take it within 2 hours of collection. Be sure to label the container with name, ID, date and time of collection
HELICOBACTER PYLORI (in feces)
Type of sample: Stool.
clinical significance: Helps in the diagnosis of an H. Pylori infection in adult patients. It also helps in monitoring the efficacy of antimicrobial therapy.
Indications: Do not perform the test before 2 weeks after completing the ingestion of bismuth preparations and proton pump inhibitor antibiotics. Do not perform before 4 weeks after having finished the ingestion of antibiotics.
Note: Check with your doctor if you have been receiving any of these medicines.
Type of sample: Stool.
clinical significance: Helps in the diagnosis of an H. Pylori infection in adult patients. It also helps in monitoring the efficacy of antimicrobial therapy.
Indications: Do not perform the test before 2 weeks after completing the ingestion of bismuth preparations and proton pump inhibitor antibiotics. Do not perform before 4 weeks after having finished the ingestion of antibiotics.
Note: Check with your doctor if you have been receiving any of these medicines.
HELICOBACTER PYLORI (IgG, IgA)
Type of sample: Serum, plasma (EDTA, Heparin).
clinical significance: Associated with gastritis, peptic ulcer, and gastric adenocarcinoma.
Indications: N/A
Type of sample: Serum, plasma (EDTA, Heparin).
clinical significance: Associated with gastritis, peptic ulcer, and gastric adenocarcinoma.
Indications: N/A
HEMOGLOBIN A2
Type of sample: Whole blood.
clinical significance: Diagnosis of thalassemias.
Indications: N/A
Type of sample: Whole blood.
clinical significance: Diagnosis of thalassemias.
Indications: N/A
FETAL HEMOGLOBIN
Type of sample: Whole blood.
clinical significance: Identify patients with persistence of fetal hemoglobin.
Indications: N/A
Type of sample: Whole blood.
clinical significance: Identify patients with persistence of fetal hemoglobin.
Indications: N/A
GLYCOSYLATED HEMOGLOBIN (Hemoglobin A1C)
Type of sample: Whole blood.
clinical significance: To assist in the control of blood glucose level. To monitor the efficiency of diet control and therapy during the treatment of diabetes.
Indications: N/A
Type of sample: Whole blood.
clinical significance: To assist in the control of blood glucose level. To monitor the efficiency of diet control and therapy during the treatment of diabetes.
Indications: N/A
HEMOGLOBIN S (QUANTIFICATION)
Indications: (See Hemoglobin Electrophoresis)
Indications: (See Hemoglobin Electrophoresis)
PAROXYSTIC NOCTURNAL HEMOGLOBINURIA (PNH) WITH FLAER
Indications: Sampling Monday or Wednesday before 9 am for sample stability
Indications: Sampling Monday or Wednesday before 9 am for sample stability
COMPLETE BLOOD COUNT
Description:: Includes Leukocyte Count, Erythrocytes, Hemoglobin, Hematocrit, Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin, Mean Corpuscular Hemoglobin Concentration, Count
of Platelets, Distribution of erythrocytes or RDW, Mean Platelet Volume (MPV) or MPV, Automated or manual Differential.
clinical significance: For the diagnosis of many diseases and other conditions.
Indications: N/A
Description:: Includes Leukocyte Count, Erythrocytes, Hemoglobin, Hematocrit, Mean Corpuscular Volume (MCV), Mean Corpuscular Hemoglobin, Mean Corpuscular Hemoglobin Concentration, Count
of Platelets, Distribution of erythrocytes or RDW, Mean Platelet Volume (MPV) or MPV, Automated or manual Differential.
clinical significance: For the diagnosis of many diseases and other conditions.
Indications: N/A
HEPATITIS A, IgM Antibody
Type of sample: Serum or plasma.
clinical significance: The detection of Hepatitis A IgM is an aid for the diagnosis of acute hepatitis.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: The detection of Hepatitis A IgM is an aid for the diagnosis of acute hepatitis.
Indications: N/A
HEPATITIS B ANTIGEN
Indications: If you are taking biotin, you should stop taking it 72 hours before taking the sample.
Indications: If you are taking biotin, you should stop taking it 72 hours before taking the sample.
HEPATITIS B, ANTI-CORE TOTAL
Type of sample: Serum, plasma.
clinical use: The Core Antibody can be positive when symptoms of hepatitis B appear and can persist for up to a year.
Indications: N/A
Type of sample: Serum, plasma.
clinical use: The Core Antibody can be positive when symptoms of hepatitis B appear and can persist for up to a year.
Indications: N/A
HEPATITIS B, SURFACE ANTIGEN (HbsAg)
Type of sample: Serum, plasma.
clinical use: Diagnosis of hepatitis B virus infections.
Indications: N/A
Type of sample: Serum, plasma.
clinical use: Diagnosis of hepatitis B virus infections.
Indications: N/A
HEPATITIS B, ANTI-HBs (Antibodies against B surface antigen)
Type of sample: Serum or plasma.
clinical significance: This assay is often used to monitor the success of the hepatitis B vaccine.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: This assay is often used to monitor the success of the hepatitis B vaccine.
Indications: N/A
HEPATITIS C VIRAL RNA, QUALITATIVE
Indications: TMA (transcription mediated amplification).
Indications: TMA (transcription mediated amplification).
HEPATITIS C, Antibody
Type of sample: Serum, plasma.
clinical significance: Diagnosis of Hepatitis C infection.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Diagnosis of Hepatitis C infection.
Indications: N/A
HERPES SIMPLEX VIRUS TYPE I; IgG, IgM
Type of sample: Serum, plasma (EDTA, Heparin).
clinical significance: Test for the detection of herpes simplex virus types I and II, which are pathogens present in humans that cause asymptomatic infections such as mild skin and mucous diseases.
Indications: N/A
Type of sample: Serum, plasma (EDTA, Heparin).
clinical significance: Test for the detection of herpes simplex virus types I and II, which are pathogens present in humans that cause asymptomatic infections such as mild skin and mucous diseases.
Indications: N/A
HERPES SIMPLEX VIRUS TYPE II; IgG, IgM
Type of sample: Serum, plasma.
clinical significance: Test for the detection of herpes simplex virus types I and II, which are pathogens present in humans that cause asymptomatic infections such as mild skin and mucous diseases.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Test for the detection of herpes simplex virus types I and II, which are pathogens present in humans that cause asymptomatic infections such as mild skin and mucous diseases.
Indications: N/A
HYDROXYPROGESTERONE 17OH (not neonatal)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
HYDROXYPROGESTERONE 17OH NEONATAL
Type of sample: Total capillary blood, heel (card).
clinical significance: Used to test babies for an inherited disorder that affects the adrenal glands.
Indications: N/A
Type of sample: Total capillary blood, heel (card).
clinical significance: Used to test babies for an inherited disorder that affects the adrenal glands.
Indications: N/A
HYDROXYPROLINE
Indications: Fast overnight (or at least 4 hours after a meal). Non-fasting samples are acceptable for pediatric patients.
Indications: Fast overnight (or at least 4 hours after a meal). Non-fasting samples are acceptable for pediatric patients.
IRON
Type of sample: Serum or plasma.
clinical significance: Differential diagnosis between anemia, nephrosis, cirrhosis and hepatitis.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: Differential diagnosis between anemia, nephrosis, cirrhosis and hepatitis.
Indications: N/A
IRON, FIXING CAPACITY (IBCT).
Indications: (See Transferrin)
Indications: (See Transferrin)
HISTAMINE
Indications: Avoid drugs that cause allergies, antihistamines, oral corticosteroids and substances that block H2 receptors, 24 hours before collection.
Indications: Avoid drugs that cause allergies, antihistamines, oral corticosteroids and substances that block H2 receptors, 24 hours before collection.
HISTAMINE / HISTAMINE RELEASE FROM LEUKOCYTES
Indications: Patients taking calcineurin inhibitors must suspend their medication for 72 hours before sample collection.
Indications: Patients taking calcineurin inhibitors must suspend their medication for 72 hours before sample collection.
HISTONE, ANTIBODIES
Indications: Overnight fasting is preferred.
Indications: Overnight fasting is preferred.
HOMOCYSTEINE
Type of sample: Serum, plasma.
clinical significance: An elevation of Homocysteine is associated with a deficiency of Vitamins B2, B6, B12 and Folic Acid. It is also useful in the diagnosis of Homocysteine.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: An elevation of Homocysteine is associated with a deficiency of Vitamins B2, B6, B12 and Folic Acid. It is also useful in the diagnosis of Homocysteine.
Indications: N/A
I
IGF-1
Indications: Somatomedin-C, Insulin Like Growth Factor.
Indications: Somatomedin-C, Insulin Like Growth Factor.
IGF-1 (SOMATOMEDIN C)
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
IGF-2
Indications: Overnight fasting is preferred. Alternative names: Insulin Like Growth Factor 2, Somatomedin A.
Indications: Overnight fasting is preferred. Alternative names: Insulin Like Growth Factor 2, Somatomedin A.
IGG (IMMUNOGLOBULIN G) SUBCLASSES
Indications: There are Subclasses 1,2,3, 4.
Indications: There are Subclasses 1,2,3, 4.
IGG INDEX OF SYNTHESIS IN CSF (cerebrospinal fluid)
Indications: Includes Leukocyte Count, Erythrocytes, Hemoglobin, Hematocrit, Mean Corpuscular Volume.
Indications: Includes Leukocyte Count, Erythrocytes, Hemoglobin, Hematocrit, Mean Corpuscular Volume.
INFLUENZA type A / B / A H1N1 – PCR
Type of sample: Nasal Washes/Aspirates and Nasopharyngeal Swabs
clinical significance: It is intended for the qualitative detection of influenza A, influenza B and 2009 H1N1 viruses and Respiratory Syncytial Virus.
Indications: N/A
Type of sample: Nasal Washes/Aspirates and Nasopharyngeal Swabs
clinical significance: It is intended for the qualitative detection of influenza A, influenza B and 2009 H1N1 viruses and Respiratory Syncytial Virus.
Indications: N/A
INFLUENZA type A / B and RSV (Respiratory Syncytial Virus) – PCR
Type of sample: Nasal Washes/Aspirates and Nasopharyngeal Swabs
clinical significance: It is intended for the qualitative detection of influenza A, influenza B and 2009 H1N1 viruses and Respiratory Syncytial Virus.
Indications: N/A
Type of sample: Nasal Washes/Aspirates and Nasopharyngeal Swabs
clinical significance: It is intended for the qualitative detection of influenza A, influenza B and 2009 H1N1 viruses and Respiratory Syncytial Virus.
Indications: N/A
IMMUNOELECTROPHORESIS (Bence Jones Proteins, Free Light Chains).
Type of sample: Serum, urine.
clinical significance: Diagnosis of Multiple Myeloma.
Indications: N/A
Type of sample: Serum, urine.
clinical significance: Diagnosis of Multiple Myeloma.
Indications: N/A
IMMUNOGLOBULIN A (IgA)
Type of sample: Serum.
clinical significance: Used in the diagnosis and treatment of immunodeficiency conditions, protein loss, chronic infections, myeloma, and liver disease.
Indications: N/A
Type of sample: Serum.
clinical significance: Used in the diagnosis and treatment of immunodeficiency conditions, protein loss, chronic infections, myeloma, and liver disease.
Indications: N/A
IMMUNOGLOBULIN E (IgE)
Type of sample: Serum, plasma.
clinical significance: High concentrations in allergies, asthma, parasitic diseases, atopic dermatitis.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: High concentrations in allergies, asthma, parasitic diseases, atopic dermatitis.
Indications: N/A
IMMUNOGLOBULIN G (IgG)
Type of sample: Serum.
clinical significance: Its values are used in the diagnosis and treatment of immunodeficiency conditions, protein loss, chronic infections, liver disease, multiple sclerosis, mumps, meningitis and IgG myeloma.
Indications: N/A
Type of sample: Serum.
clinical significance: Its values are used in the diagnosis and treatment of immunodeficiency conditions, protein loss, chronic infections, liver disease, multiple sclerosis, mumps, meningitis and IgG myeloma.
Indications: N/A
IMMUNOGLOBULIN M (IgM)
Type of sample: Serum.
clinical significance: Useful in the diagnosis and treatment of immunodeficiency, protein loss, Waldestrom's macroglobulinemia, chronic infections and liver diseases.
Indications: N/A
Type of sample: Serum.
clinical significance: Useful in the diagnosis and treatment of immunodeficiency, protein loss, Waldestrom's macroglobulinemia, chronic infections and liver diseases.
Indications: N/A
INSULIN
Type of sample: Serum, plasma.
clinical significance: Useful in the diagnosis of hyperinsulinemia in hypoglycemic patients. Hyperinsulinemia may be due to an insulin-producing tumor (insulinoma), insulin resistance, or persistent hyperinsulinemia hypoglycemia.
Indications: Fasting is required.
Type of sample: Serum, plasma.
clinical significance: Useful in the diagnosis of hyperinsulinemia in hypoglycemic patients. Hyperinsulinemia may be due to an insulin-producing tumor (insulinoma), insulin resistance, or persistent hyperinsulinemia hypoglycemia.
Indications: Fasting is required.
INTERLEUKIN (IL-6)
Type of sample: Serum, plasma.
clinical significance: Interleukin 6 (IL-6) is a multifunctional protein that regulates the immune response, acute phase reactions, and hematopoiesis. IL-6 is produced by lymphoid and non-lymphoid cells, as well as normal and transformed cells, T lymphocytes, B lymphocytes, monocytes, fibroblasts, vascular endothelial cells, cardiac myxomas, bladder carcinomas, myelomas, astrocytomas, and glioblastomas.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Interleukin 6 (IL-6) is a multifunctional protein that regulates the immune response, acute phase reactions, and hematopoiesis. IL-6 is produced by lymphoid and non-lymphoid cells, as well as normal and transformed cells, T lymphocytes, B lymphocytes, monocytes, fibroblasts, vascular endothelial cells, cardiac myxomas, bladder carcinomas, myelomas, astrocytomas, and glioblastomas.
Indications: N/A
K
KOH, PREPARATION
Type of sample: Scraping lesion
clinical significance: Determine the presence of fungi and yeasts in the clinical sample.
Indications: N/A
Type of sample: Scraping lesion
clinical significance: Determine the presence of fungi and yeasts in the clinical sample.
Indications: N/A
L
LACTOFERRIN
Indications: See Qualitative Calprotectin
Indications: See Qualitative Calprotectin
LAMOTRIGINE
Indications: Take sample 1/2 to 1 hour before the next dose at steady state.
Indications: Take sample 1/2 to 1 hour before the next dose at steady state.
QUALITATIVE LEGIONELLA DNA (PCR)
Sample: Nasopharyngeal or oropharyngeal swab.
Sample: Nasopharyngeal or oropharyngeal swab.
LEPTOSPIRA
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
LEVETIRACETAM (KEPPRA)
Indications: Optimal time to collect the sample: 1/2 to 1 hour pre-oral dose, minimum at steady state (2 weeks after the start of treatment).
Indications: Optimal time to collect the sample: 1/2 to 1 hour pre-oral dose, minimum at steady state (2 weeks after the start of treatment).
LYMPHOCYTES / B CELLS / T CELLS
Indications: Sampling on Monday or Wednesday before 9 am due to the stability of the sample.
Indications: Sampling on Monday or Wednesday before 9 am due to the stability of the sample.
T LYMPHOCYTES, CD3, CD4, CD8, COUNT AND RELATION
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
LYMPHOCYTES, PANEL 1
Indications: Sampling on Monday or Wednesday before 9 am due to the stability of the sample.
Includes: ABSOLUTE LYMPHOCYTES, CD3 (T CELLS), CD4, CD8, CD16 / CD56 (NK CELLS) AND CD 19 (B CELLS)
Indications: Sampling on Monday or Wednesday before 9 am due to the stability of the sample.
Includes: ABSOLUTE LYMPHOCYTES, CD3 (T CELLS), CD4, CD8, CD16 / CD56 (NK CELLS) AND CD 19 (B CELLS)
LIPASE
Type of sample: Serum, plasma.
clinical significance: Lipase is an enzyme produced by the pancreas. It is used in the diagnosis and treatment of pancreatic disorders.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Lipase is an enzyme produced by the pancreas. It is used in the diagnosis and treatment of pancreatic disorders.
Indications: N/A
LIPIDS, PROFILE
Includes: Cholesterol, Triglycerides, HDL, LDL) See independently.
Indications: Fasting is required.
Includes: Cholesterol, Triglycerides, HDL, LDL) See independently.
Indications: Fasting is required.
LIPOPROTEIN ASSOCIATED WITH PHOSPHOLIPASE A2 (LP-PLA2)
Indications: Preferable to be fasting but it is not required.
Indications: Preferable to be fasting but it is not required.
EUGLOBULIN LYSIS
Indications: Patient should not exercise before taking sample.
Indications: Patient should not exercise before taking sample.
LITHIUM
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
LUTEINIZING HORMONE (LH)
Type of sample: Serum or plasma.
clinical significance: Useful in the evaluation of gonadal dysfunction.
Indications: Patient should not exercise before taking sample.
Type of sample: Serum or plasma.
clinical significance: Useful in the evaluation of gonadal dysfunction.
Indications: Patient should not exercise before taking sample.
M
MACROPROLACTIN, INCLUDES TOTAL AND MONOMER PROLACTIN
Indications: Preferable to be fasting but it is not required.
Indications: Preferable to be fasting but it is not required.
MAGNESIUM
Type of sample: Serum, plasma, urine.
clinical significance: Decreases related to low concentrations of Ca and K.
Indications: Patient should not exercise before taking sample.
Type of sample: Serum, plasma, urine.
clinical significance: Decreases related to low concentrations of Ca and K.
Indications: Patient should not exercise before taking sample.
MALARIA (RAPID TEST)
Type of sample: Whole blood (EDTA).
clinical significance: Test for the detection of malaria infection.
Indications: N/A
Type of sample: Whole blood (EDTA).
clinical significance: Test for the detection of malaria infection.
Indications: N/A
PLATELET MAPPING
Type of sample: Whole blood citrate and sodium heparin.
clinical significance: Monitor the coagulation cascade.
Indications: N/A
Type of sample: Whole blood citrate and sodium heparin.
clinical significance: Monitor the coagulation cascade.
Indications: N/A
MARIJUANA (CANNABIS)
Type of sample: Random urine.
Type of sample: Random urine.
MERCURY
Indications: Do not eat shellfish during the 48 hours prior to sampling
Indications: Do not eat shellfish during the 48 hours prior to sampling
HEAVY METALS, PANEL (INCLUDES ARSENIC, LEAD AND MERCURY)
Indications: Avoid consumption of shellfish during the 48 hours prior to sampling.
Indications: Avoid consumption of shellfish during the 48 hours prior to sampling.
METHANEPHRINE IN URINE AND BLOOD
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
METHANEPHRINE, FREE AND FRACTIONATED (INCLUDES METHANEPHRINE, NORMETHANEPHRINE AND TOTAL METHANEPHRINE)
Indications: Avoid alcohol, tobacco, coffee, tea for 3 days prior to taking the sample and vigorous exercise, you must be relaxed. Preferably fast overnight. Begin urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Avoid alcohol, tobacco, coffee, tea for 3 days prior to taking the sample and vigorous exercise, you must be relaxed. Preferably fast overnight. Begin urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
MICRO PROTEIN
Type of sample: In urine, CSF (cerebrospinal fluid) and other body fluids.
Type of sample: In urine, CSF (cerebrospinal fluid) and other body fluids.
MICROALBUMINURIA
Type of sample: Random or 24-hour urine.
clinical significance: Micro albumin is the albumin detected in the urine. Microalbuminuria is a sensitive marker of nephropathy.
Indications: N/A
Type of sample: Random or 24-hour urine.
clinical significance: Micro albumin is the albumin detected in the urine. Microalbuminuria is a sensitive marker of nephropathy.
Indications: N/A
MICROPROTEIN (In urine, CSF and other body fluids)
Type of sample: Urine, CSF, body fluids.
clinical significance: Increased protein in cerebrospinal fluid (CSF) is seen in meningitis, polyneuritis, and some tumors. The increase in urine is associated with hypergammaglobulinemia nephrosis.
Indications: N/A
Type of sample: Urine, CSF, body fluids.
clinical significance: Increased protein in cerebrospinal fluid (CSF) is seen in meningitis, polyneuritis, and some tumors. The increase in urine is associated with hypergammaglobulinemia nephrosis.
Indications: N/A
MYELIN, BASIC PROTEIN
Type of sample: In cerebrospinal fluid.
Type of sample: In cerebrospinal fluid.
MONONUCLEOSIS IgM (RAPID TEST)
Type of sample: Serum, plasma.
clinical significance: For the detection of infectious mononucleosis caused by the Epstein Barr virus.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: For the detection of infectious mononucleosis caused by the Epstein Barr virus.
Indications: N/A
MPL MUTATION ANALYSIS
Indications: Take samples on Mondays or Wednesdays before 9 am due to the stability of the sample.
Indications: Take samples on Mondays or Wednesdays before 9 am due to the stability of the sample.
SMOOTH MUSCLE, Total Antibodies
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
MYCOBACTERIUM TUBERCULOSIS (PCR)
Indications: It is required to fill out the form.
Indications: It is required to fill out the form.
MYCOBACTERIUM TUBERCULOSIS / MTB / RIF
Type of sample: Sputum, endotracheal secretion, bronchial lavage.
clinical significance: It is used for the detection of Mycobacterium tuberculosis DNA compounds in sputum samples or in concentrated sediments prepared from expectorated sputa whose smears are both positive and negative for acid-fast bacilli (AFB).
Indications: N/A
Type of sample: Sputum, endotracheal secretion, bronchial lavage.
clinical significance: It is used for the detection of Mycobacterium tuberculosis DNA compounds in sputum samples or in concentrated sediments prepared from expectorated sputa whose smears are both positive and negative for acid-fast bacilli (AFB).
Indications: N/A
MYCOPLASMA PNEUMONIAE IGM
Type of sample: Serum.
clinical significance: Infections by Mycoplasma pneumoniae.
Indications: N/A
Type of sample: Serum.
clinical significance: Infections by Mycoplasma pneumoniae.
Indications: N/A
N
UREA NITROGEN (BUN)
Type of sample: Serum, plasma, urine.
clinical significance: Urea is filtered through the kidneys. Urea nitrogen is a test of kidney function that is interpreted with creatinine.
Indications: N/A
Type of sample: Serum, plasma, urine.
clinical significance: Urea is filtered through the kidneys. Urea nitrogen is a test of kidney function that is interpreted with creatinine.
Indications: N/A
INFLIXIMAB AND DRUG ANTIBODY LEVEL FOR IBD (INFLAMATORY BOWEL DISEASE)
Indications: Up to 48 hours before the blood draw, do not take multivitamins or dietary supplements that contain biotin or vitamin B7. Blood should be drawn just before the next infliximab infusion to measure the trough level of the drug.
Indications: Up to 48 hours before the blood draw, do not take multivitamins or dietary supplements that contain biotin or vitamin B7. Blood should be drawn just before the next infliximab infusion to measure the trough level of the drug.
NT-PRO BNP
Type of sample: Whole blood EDTA. Plasma heparin sodium, lithium, EDTA.
clinical significance: Facilitates diagnosis in patients with suspected congestive heart disease.
Indications: N/A
Type of sample: Whole blood EDTA. Plasma heparin sodium, lithium, EDTA.
clinical significance: Facilitates diagnosis in patients with suspected congestive heart disease.
Indications: N/A
N-TELOPEPTIDE SERUM (COLLAGEN CROSS LINKS)
Indications: If it is random urine, you should collect the second urine in the morning.
Indications: If it is random urine, you should collect the second urine in the morning.
O
OMEGA 3-6
Indications: Overnight fasting is required.
Indications: Overnight fasting is required.
GENERAL URINE
Type of sample: Urine. Request collection instructions.
clinical significance: Basic general test to rule out many diseases, especially renal.
Indications: It is preferable that the sample is collected in the laboratory. Use a clean and/or sterile container for urine collection. Thoroughly clean the genital area with soap and water. Rinse with plenty of water to remove soap. Be careful not to touch the edge or inside of the container to avoid contaminating it. Urinate into the bottle, discarding the first stream of urine. Close the container tightly and deliver it to the laboratory. Be sure to label the container with full name, ID/passport, date and time of collection. The best urine sample is the first thing in the morning when you get up. If you collect the sample at home, it should not take more than half an hour to bring it to the laboratory to be analyzed.
Type of sample: Urine. Request collection instructions.
clinical significance: Basic general test to rule out many diseases, especially renal.
Indications: It is preferable that the sample is collected in the laboratory. Use a clean and/or sterile container for urine collection. Thoroughly clean the genital area with soap and water. Rinse with plenty of water to remove soap. Be careful not to touch the edge or inside of the container to avoid contaminating it. Urinate into the bottle, discarding the first stream of urine. Close the container tightly and deliver it to the laboratory. Be sure to label the container with full name, ID/passport, date and time of collection. The best urine sample is the first thing in the morning when you get up. If you collect the sample at home, it should not take more than half an hour to bring it to the laboratory to be analyzed.
URINE, DRUG PANEL (6 TESTS)
Type of sample: Random urine.
clinical significance: To monitor drugs of abuse.
Indications: N/A
Type of sample: Random urine.
clinical significance: To monitor drugs of abuse.
Indications: N/A
OSMOLARITY (SERUM)
Type of sample: Serum.
clinical significance: Useful in the evaluation of comatose or acutely ill patients who may have ingested ethylene glycol, methanol, isopropanol, or other poisons that affect the interval between measured and calculated osmolarity.
Indications: N/A
Type of sample: Serum.
clinical significance: Useful in the evaluation of comatose or acutely ill patients who may have ingested ethylene glycol, methanol, isopropanol, or other poisons that affect the interval between measured and calculated osmolarity.
Indications: N/A
URINE OSMOLARITY
Type of sample: Urine.
clinical significance: Evaluate the concentration ability of the kidneys. Urinary osmolarity depends on the diet of salts and water.
Indications: N/A
Type of sample: Urine.
clinical significance: Evaluate the concentration ability of the kidneys. Urinary osmolarity depends on the diet of salts and water.
Indications: N/A
OXALATE (OXALIC ACID)
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
P
PNEUMONIA PANEL
Type of sample: Sputum swab, endotracheal, bronchial lavage.
clinical significance: Detects 34 pathogens. The BIOFIRE® FILMARRAY® Respiratory Panel 2 plus provides a comprehensive diagnostic tool for pneumonia and other lower respiratory tract infections. Rapid and accurate identification of the causative agent of both community-associated and healthcare-associated respiratory infections can help improve patient management by informing timely and effective antibiotic or antiviral therapy.
Indications: N/A
Type of sample: Sputum swab, endotracheal, bronchial lavage.
clinical significance: Detects 34 pathogens. The BIOFIRE® FILMARRAY® Respiratory Panel 2 plus provides a comprehensive diagnostic tool for pneumonia and other lower respiratory tract infections. Rapid and accurate identification of the causative agent of both community-associated and healthcare-associated respiratory infections can help improve patient management by informing timely and effective antibiotic or antiviral therapy.
Indications: N/A
SEPSIS PANEL
Type of sample: Positive blood culture.
clinical significance: Sepsis is a very serious problem and can cause tragic complications, so it is essential that patients undergo targeted therapy, the rapid identification of microorganisms through the sepsis panel allows adequate therapy.
Indications: N/A
Type of sample: Positive blood culture.
clinical significance: Sepsis is a very serious problem and can cause tragic complications, so it is essential that patients undergo targeted therapy, the rapid identification of microorganisms through the sepsis panel allows adequate therapy.
Indications: N/A
GASTROINTESTINAL PANEL
Type of sample: Liquid feces.
clinical significance: Tests for the most common gastrointestinal pathogens including viruses, bacteria and parasites that cause infectious diarrhea and other gastrointestinal symptoms. It is very useful as it provides doctors with the necessary information to make the best treatment decisions and achieve better results for the patient and a reduction in healthcare costs.
Indications: The stool sample must be liquid.
Type of sample: Liquid feces.
clinical significance: Tests for the most common gastrointestinal pathogens including viruses, bacteria and parasites that cause infectious diarrhea and other gastrointestinal symptoms. It is very useful as it provides doctors with the necessary information to make the best treatment decisions and achieve better results for the patient and a reduction in healthcare costs.
Indications: The stool sample must be liquid.
MENINGEAL PANEL, PCR
Type of sample: Cerebrospinal fluid.
clinical significance: Detects 14 pathogens responsible for community-acquired meningitis or encephalitis including viruses, bacteria and yeasts.
Indications: N/A
Type of sample: Cerebrospinal fluid.
clinical significance: Detects 14 pathogens responsible for community-acquired meningitis or encephalitis including viruses, bacteria and yeasts.
Indications: N/A
RESPIRATORY PANEL
Type of sample: Nasopharyngeal swab.
Volume/ Minimum amount of sample: 300uL.
Stability: 3 days from 2 to 8°C, 1 month at -20°C.
Container: Viral transport medium.
Methodology: Real-time PCR.
Test analysis days: Every day.
available results: 8 hours.
Significance/ Clinical Use: A rapid and accurate identification of the causative agent of upper respiratory tract infections can improve the management of the patient informed in a timely and effective manner about antibiotic or antiviral therapy.
Indications: N/A
Type of sample: Nasopharyngeal swab.
Volume/ Minimum amount of sample: 300uL.
Stability: 3 days from 2 to 8°C, 1 month at -20°C.
Container: Viral transport medium.
Methodology: Real-time PCR.
Test analysis days: Every day.
available results: 8 hours.
Significance/ Clinical Use: A rapid and accurate identification of the causative agent of upper respiratory tract infections can improve the management of the patient informed in a timely and effective manner about antibiotic or antiviral therapy.
Indications: N/A
PARATHORMONE-INTACT PTH
Type of sample: Serum, plasma.
clinical significance: PTH is present in autoimmune disorders involving the parathyroid glands and is associated with hypoparathyroidism and differential diagnosis of hypercalcemia.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: PTH is present in autoimmune disorders involving the parathyroid glands and is associated with hypoparathyroidism and differential diagnosis of hypercalcemia.
Indications: N/A
PCT (PROCALCITONIN)
Type of sample: Serum, plasma.
clinical significance: PCT is an important indicator that allows specific differentiation between a bacterial infection and other causes of inflammatory reactions.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: PCT is an important indicator that allows specific differentiation between a bacterial infection and other causes of inflammatory reactions.
Indications: N/A
PEPSINOGEN I
Indications: You must fast for 10 – 12 hours prior to sample collection. Avoid antacids or medications that affect stomach acidity for at least 48 hours before sample collection.
Indications: You must fast for 10 – 12 hours prior to sample collection. Avoid antacids or medications that affect stomach acidity for at least 48 hours before sample collection.
PEPSINOGEN II
Indications: Patient must fast for 10 – 12 hours prior to sample collection. Avoid antacids or medications that affect stomach acidity for at least 48 hours before sample collection.
Indications: Patient must fast for 10 – 12 hours prior to sample collection. Avoid antacids or medications that affect stomach acidity for at least 48 hours before sample collection.
PEPTIDE C
Indications: A 12-hour fast is required.
Indications: A 12-hour fast is required.
VASOACTIVE INTESTINAL PEPTIDE (VIP)
Indications: Fasting for 8 hours is required and not having received radiation.
Indications: Fasting for 8 hours is required and not having received radiation.
EXPANDED LIPID PROFILE (CARDIO IQ)
Note: Cardio IQ Lipoprotein Fractionation ION Mobility. Includes: LDL Particles, LDL Small, LDL Medium, HDL Large, LDLPeak Size, LDL Pattern.
Indications: Preferably fasting but if you are not fasting it is acceptable. Charts are not reported in patients under 21 years of age. Do not take if you take N-acetyl cysteine.
Note: Cardio IQ Lipoprotein Fractionation ION Mobility. Includes: LDL Particles, LDL Small, LDL Medium, HDL Large, LDLPeak Size, LDL Pattern.
Indications: Preferably fasting but if you are not fasting it is acceptable. Charts are not reported in patients under 21 years of age. Do not take if you take N-acetyl cysteine.
ADVANCED LIPID PROFILE (CARDIO IQ)
Includes: Cardio IQ® Cholesterol, Total, Cardio IQ® HDL Cholesterol, Cardio IQ® Triglycerides, Cardio IQ® Non-HDL and Calculated Components, Cardio IQ® Lipoprotein Fractionation, Ion Mobility (CardioIQ Expanded), Cardio IQ® Apolipoprotein B, Cardio IQ ® Lipoprotein (a).
Indications: Preferably fasting but if you are not fasting it is acceptable. Charts are not reported in patients under 21 years of age. Indicate if you take N-acetyl cysteine and if you have a history of triglyceride > 400 mg/dL.
Includes: Cardio IQ® Cholesterol, Total, Cardio IQ® HDL Cholesterol, Cardio IQ® Triglycerides, Cardio IQ® Non-HDL and Calculated Components, Cardio IQ® Lipoprotein Fractionation, Ion Mobility (CardioIQ Expanded), Cardio IQ® Apolipoprotein B, Cardio IQ ® Lipoprotein (a).
Indications: Preferably fasting but if you are not fasting it is acceptable. Charts are not reported in patients under 21 years of age. Indicate if you take N-acetyl cysteine and if you have a history of triglyceride > 400 mg/dL.
ADVANCED LIPID PROFILE + INFLAMMATION (CARDIO IQ)
Includes: Cardio IQ® Cholesterol, Total, Cardio IQ® HDL Cholesterol, Cardio IQ® Triglycerides, Cardio IQ® Non-HDL and Calculated Components, Cardio IQ® Lipoprotein Fractionation, Ion Mobility (CardioIQ Expanded), Cardio IQ® Apolipoprotein B, Cardio IQ ® Lipoprotein (a), Cardio IQ® hs-CRP, Cardio IQ® Lp-PLA2 Activity.
Indications: Preferably fasting but if you are not fasting it is acceptable. Charts are not reported in patients under 21 years of age. Indicate if you take N-acetyl cysteine and if you have a history of triglyceride > 400 mg/dL.
Includes: Cardio IQ® Cholesterol, Total, Cardio IQ® HDL Cholesterol, Cardio IQ® Triglycerides, Cardio IQ® Non-HDL and Calculated Components, Cardio IQ® Lipoprotein Fractionation, Ion Mobility (CardioIQ Expanded), Cardio IQ® Apolipoprotein B, Cardio IQ ® Lipoprotein (a), Cardio IQ® hs-CRP, Cardio IQ® Lp-PLA2 Activity.
Indications: Preferably fasting but if you are not fasting it is acceptable. Charts are not reported in patients under 21 years of age. Indicate if you take N-acetyl cysteine and if you have a history of triglyceride > 400 mg/dL.
PFA – 100 (PLATELES- SHUTTING TIME)
Type of sample: Whole blood with sodium citrate, Request instructions.
clinical significance: PFA systems recognize abnormalities in platelet function.
Indications: N/A
Type of sample: Whole blood with sodium citrate, Request instructions.
clinical significance: PFA systems recognize abnormalities in platelet function.
Indications: N/A
LEAD
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
POTASSIUM
Type of sample: Serum, plasma, urine.
clinical significance: Potassium is a cellular element involved in critical cellular functions.
Indications: N/A
Type of sample: Serum, plasma, urine.
clinical significance: Potassium is a cellular element involved in critical cellular functions.
Indications: N/A
PRE-ALBUMIN
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
PROGESTERONE
Type of sample: Serum.
clinical significance: Progesterone levels indicate the viability of the pregnancy.
Indications: N/A
Type of sample: Serum.
clinical significance: Progesterone levels indicate the viability of the pregnancy.
Indications: N/A
PROINSULIN
Indications: Overnight fasting is required.
Indications: Overnight fasting is required.
PROLACTIN
Type of sample: Serum, plasma.
clinical significance: Essential pituitary hormone for initiation and maintenance of lactation. Elevated prolactin values indicate galactorrhea, amenorrhea, hypothalamic and pituitary diseases, pituitary tumors due to prolactin secretion, liver and kidney damage, insulin-induced hypoglycemia. Decreased values can be found in Sheehan's Syndrome (pituitary apoplexy) and idiopathic hypogonadotropic hypogonadism.
Indications: Overnight fasting is required.
Type of sample: Serum, plasma.
clinical significance: Essential pituitary hormone for initiation and maintenance of lactation. Elevated prolactin values indicate galactorrhea, amenorrhea, hypothalamic and pituitary diseases, pituitary tumors due to prolactin secretion, liver and kidney damage, insulin-induced hypoglycemia. Decreased values can be found in Sheehan's Syndrome (pituitary apoplexy) and idiopathic hypogonadotropic hypogonadism.
Indications: Overnight fasting is required.
HIGH SENSITIVITY C REACTIVE PROTEIN (hs -CRP)
Type of sample: Serum or plasma.
clinical significance: Used in the clinical evaluation of stress, trauma, infection, inflammation, and surgery.
Indications: N/A
Type of sample: Serum or plasma.
clinical significance: Used in the clinical evaluation of stress, trauma, infection, inflammation, and surgery.
Indications: N/A
PROTEIN C and S
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
TOTAL PROTEIN
Type of sample: Serum, plasma.
clinical significance: Total protein is useful in tracking changes in protein levels that cause various disease states.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Total protein is useful in tracking changes in protein levels that cause various disease states.
Indications: N/A
R
CELL COUNT IN BODY FLUIDS (Synovial, Pleural, Ascitic Fluid, others)
Type of sample: Liquid collected aseptically with a sterile plastic syringe for Microbiology.
clinical significance: Helps in the diagnosis of specific diseases depending on the fluid being analyzed.
Indications: N/A
Type of sample: Liquid collected aseptically with a sterile plastic syringe for Microbiology.
clinical significance: Helps in the diagnosis of specific diseases depending on the fluid being analyzed.
Indications: N/A
CEREBROSPINAL FLUID (CSF) CELL COUNT
Type of sample: CSF.
clinical significance: Infections of the meninges, subcranial hemorrhage, malignant tumors of the central nervous system.
Indications: N/A
Type of sample: CSF.
clinical significance: Infections of the meninges, subcranial hemorrhage, malignant tumors of the central nervous system.
Indications: N/A
RESISTANCE TO CARBAPENEMICS, PCR
Indications: Stool sample or rectal swab.
Indications: Stool sample or rectal swab.
RESISTANCE TO CARBAPENS BY CROP
Type of sample: Rectal swab in transport medium for culture.
Clinical Significance/ Clinical Use: Determine the presence of CARBA / OXA resistance mechanisms.
Indications: N/A
Type of sample: Rectal swab in transport medium for culture.
Clinical Significance/ Clinical Use: Determine the presence of CARBA / OXA resistance mechanisms.
Indications: N/A
RESISTANCE TO CARBAPENEMICS BY PCR
Type of sample: Rectal swab in red top transport medium.
clinical significance: Determine the presence of resistance mechanisms (KPC/NDM, VIM, IMP, OXA48).
Indications: N/A
Type of sample: Rectal swab in red top transport medium.
clinical significance: Determine the presence of resistance mechanisms (KPC/NDM, VIM, IMP, OXA48).
Indications: N/A
INSULIN RESISTANCE WITH SCORING, PANEL
Indications: Overnight fasting is required.
Indications: Overnight fasting is required.
RETICULOCYTES. COUNT (included in Complete Blood Count)
Type of sample: Whole blood.
clinical significance: Reticulocytes: to determine the response and potential of the bone marrow.
Indications: N/A
Type of sample: Whole blood.
clinical significance: Reticulocytes: to determine the response and potential of the bone marrow.
Indications: N/A
RITUXAN / RITUXIMAB, SENSITIVITY (CD20)
Indications: Sampling on Monday or Wednesday before 9 am due to the stability of the sample.
Indications: Sampling on Monday or Wednesday before 9 am due to the stability of the sample.
ROTAVIRUS ADENOVIRUSES
Methodology: Qualitative immunochromatography.
clinical significance: To determine severe gastroenteritis that is detected by vomiting and diarrhea.
Indications: N/A
Methodology: Qualitative immunochromatography.
clinical significance: To determine severe gastroenteritis that is detected by vomiting and diarrhea.
Indications: N/A
RUBELLA, IGG ANTIBODIES, IGM
Type of sample: Serum, plasma.
clinical significance: Infection during pregnancy can leave sequelae of birth defects if the infection is contracted during pregnancy.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Infection during pregnancy can leave sequelae of birth defects if the infection is contracted during pregnancy.
Indications: N/A
S
HIDDEN BLOOD IN FECES
Type of sample: Fecal matter: 1 gr.
clinical significance: Diagnosis of asymptomatic gastrointestinal conditions that can be manifested by the presence of hidden blood in the feces.
Indications: The patient should not ingest vitamin C supplements, such as broccoli, cauliflower, bananas, grapes, alcohol, red meat, beets, or medications such as aspirin, 48 hours before sample collection.
Type of sample: Fecal matter: 1 gr.
clinical significance: Diagnosis of asymptomatic gastrointestinal conditions that can be manifested by the presence of hidden blood in the feces.
Indications: The patient should not ingest vitamin C supplements, such as broccoli, cauliflower, bananas, grapes, alcohol, red meat, beets, or medications such as aspirin, 48 hours before sample collection.
SELENIUM
Indications: You must refrain from taking vitamins or mineral supplements for at least three days prior to sample collection.
Indications: You must refrain from taking vitamins or mineral supplements for at least three days prior to sample collection.
SEROTONIN
Indications: You should avoid foods high in indole: avocado, banana, tomato, plum, walnut, pineapple and eggplant.
Indications: You should avoid foods high in indole: avocado, banana, tomato, plum, walnut, pineapple and eggplant.
SYPHILIS
Type of sample: Serum, plasma (EDTA, Sodium citrate).
clinical significance: For the detection of antibodies during the syphilis infection stage.
Indications: N/A
Type of sample: Serum, plasma (EDTA, Sodium citrate).
clinical significance: For the detection of antibodies during the syphilis infection stage.
Indications: N/A
SODIUM
Type of sample: Serum, Plasma, Urine.
clinical significance: Sodium is critical in maintaining osmotic and water balance in extracellular fluids. Irregularities in the balance of water and acid-bases are observed in the sodium concentration.
Indications: N/A
Type of sample: Serum, Plasma, Urine.
clinical significance: Sodium is critical in maintaining osmotic and water balance in extracellular fluids. Irregularities in the balance of water and acid-bases are observed in the sodium concentration.
Indications: N/A
GROUP A STREPTOCOCCUS
Type of sample: Throat swabs and suspected group A Streptococcus colonies in culture.
clinical significance: Detects the presence of Group A Streptococcus directly from the swab sample, providing results in 5 minutes.
Type of sample: Throat swabs and suspected group A Streptococcus colonies in culture.
clinical significance: Detects the presence of Group A Streptococcus directly from the swab sample, providing results in 5 minutes.
SUDAN II IN FECAL MATTER
Type of sample: Fecal Matter: 5 gr.
clinical significance: To determine fat in feces. Pathological pictures of Diabetes Mellitus, eclampsia, renal intoxication, chronic glomerulonephritis, lipoid nephrosis and fat embolism.
Type of sample: Fecal Matter: 5 gr.
clinical significance: To determine fat in feces. Pathological pictures of Diabetes Mellitus, eclampsia, renal intoxication, chronic glomerulonephritis, lipoid nephrosis and fat embolism.
T
FREE T3
Type of sample: Serum, plasma.
clinical significance: It is used to differentiate various kinds of hyperthyroidism.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: It is used to differentiate various kinds of hyperthyroidism.
Indications: N/A
T3 TOTAL
Type of sample: Serum, plasma.
clinical significance: To detect hyper or hypothyroidism.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: To detect hyper or hypothyroidism.
Indications: N/A
FREE T4
Type of sample: Serum, plasma.
clinical significance: To confirm thyroid dysfunction.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: To confirm thyroid dysfunction.
Indications: N/A
FREE T4 BY EQUILIBRIUM DIALYSIS (DIRECT DIALYSIS)
Indications: Fasting required.
Indications: Fasting required.
T4 TOTAL
Type of sample: Serum, plasma.
clinical significance: To detect hypo and hyperthyroidism, psychiatric conditions.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: To detect hypo and hyperthyroidism, psychiatric conditions.
Indications: N/A
TACROLIMUS
Indications: The sample should be taken 1 hour before the next dose.
Indications: The sample should be taken 1 hour before the next dose.
FREE TESTOSTERONE
Indications: Consult with the Laboratory
Indications: Consult with the Laboratory
TOTAL TESTOSTERONE
Type of sample: Serum, plasma.
clinical significance: In men it is useful for the diagnosis of hypogonadism, hypopituitarism, hyperprolactinemia, renal failure, Klinefelter's when it is decreased. In women, elevated values are found in polycystic ovarian syndrome, adrenal and ovarian tumors, and hyperplasia.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: In men it is useful for the diagnosis of hypogonadism, hypopituitarism, hyperprolactinemia, renal failure, Klinefelter's when it is decreased. In women, elevated values are found in polycystic ovarian syndrome, adrenal and ovarian tumors, and hyperplasia.
Indications: N/A
PROTHROMBIN TIME (PT)
Type of sample: Citrated plasma.
clinical significance: Pre-surgical exploration method to detect possible bleeding problems.
Indications: N/A
Type of sample: Citrated plasma.
clinical significance: Pre-surgical exploration method to detect possible bleeding problems.
Indications: N/A
BLEEDING TIME (BLEEDING)
Type of sample: Whole blood.
clinical significance: Prolonged in patients with thrombocytopenia, von Willebrand disease, Glanzmann thrombasthenia, Bernard Soulier syndrome, and other platelet disorders.
Indications: N/A
Type of sample: Whole blood.
clinical significance: Prolonged in patients with thrombocytopenia, von Willebrand disease, Glanzmann thrombasthenia, Bernard Soulier syndrome, and other platelet disorders.
Indications: N/A
PARTIAL THROMBOPLASTIN TIME (PTT)
Type of sample: Citrated plasma.
clinical significance: Pre-surgical exploration method to detect possible bleeding problems.
Indications: N/A
Type of sample: Citrated plasma.
clinical significance: Pre-surgical exploration method to detect possible bleeding problems.
Indications: N/A
THYRO-STIMULANT, ULTRA-SENSITIVE HORMONE (TSH)
Type of sample: Serum, plasma.
clinical significance: Identification of hypothyroidism and hyperthyroidism.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Identification of hypothyroidism and hyperthyroidism.
Indications: N/A
THYROGLOBULIN IgG ANTIBODIES
Type of sample: Serum, plasma.
clinical significance: Helps in the diagnosis of autoimmune thyroid dysfunctions.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Helps in the diagnosis of autoimmune thyroid dysfunctions.
Indications: N/A
THYROGLOBULIN PANEL
Indications: If you are taking biotin supplements you should suspend it for 8 hours. If you take high doses you must stop it 72 hours before taking the sample.
Indications: If you are taking biotin supplements you should suspend it for 8 hours. If you take high doses you must stop it 72 hours before taking the sample.
THYROID PEROXIDASE ANTIBODY (TPO)
Type of sample: Serum, plasma.
clinical significance: Diagnosis of thyroid dysfunctions.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Diagnosis of thyroid dysfunctions.
Indications: N/A
TOPIRAMATE
Indications: Taking a blood sample at rest: 2-4 hours after the dose (Peak / Pico). 1/2 – 1 hour before the dose (Through / During). If the doctor does not indicate whether before or after the dose, ask the patient how long it has been since the last dose and/or consult the doctor.
Indications: Taking a blood sample at rest: 2-4 hours after the dose (Peak / Pico). 1/2 – 1 hour before the dose (Through / During). If the doctor does not indicate whether before or after the dose, ask the patient how long it has been since the last dose and/or consult the doctor.
TOXOPLASMA ANTIBODIES IGG, IGM
Type of sample: Serum.
clinical significance: Toxoplasmosis is caused by an infection with the Toxoplasma gondii parasite.
Indications: N/A
Type of sample: Serum.
clinical significance: Toxoplasmosis is caused by an infection with the Toxoplasma gondii parasite.
Indications: N/A
IGA/IGG TRANSGLUTAMINASES
Type of sample: Serum, plasma.
clinical significance: Pending search......Lipids comprising 95 % of fats.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Pending search......Lipids comprising 95 % of fats.
Indications: N/A
TRIAGE (Cardiac Panel includes CKMB, Troponin, Myoglobin, Troponin I, BNP, D Dimer)
Type of sample: Whole blood/plasma.
clinical significance: For the diagnosis of myocardial infarction, in the diagnosis and assessment of the severity of heart failure, in the evaluation of those suspected of having disseminated intravascular coagulation or thromboembolic events such as pulmonary embolism, and in the risk stratification of patients with acute coronary syndrome.
Type of sample: Whole blood/plasma.
clinical significance: For the diagnosis of myocardial infarction, in the diagnosis and assessment of the severity of heart failure, in the evaluation of those suspected of having disseminated intravascular coagulation or thromboembolic events such as pulmonary embolism, and in the risk stratification of patients with acute coronary syndrome.
TRIGLYCERIDES
Type of sample: Serum, plasma.
clinical significance: High concentrations are associated with increased risk of cardiovascular disease.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: High concentrations are associated with increased risk of cardiovascular disease.
Indications: N/A
TRIPLE MATERNAL MARKER 2nd TRIMESTER (BHCG, uE3, AFP)
Type of sample: Serum (15 to 20 weeks).
clinical significance: Used to diagnose Down Syndrome, Edwards Syndrome, and open tube defects. This profile includes AFP, Free Estriol and BhCG.
Note: It is necessary to know the probable date of delivery, the patient's date of birth, weight, race, diabetic status, number of deliveries and if she has a history of neural tube defects for the interpretation of the results.
Type of sample: Serum (15 to 20 weeks).
clinical significance: Used to diagnose Down Syndrome, Edwards Syndrome, and open tube defects. This profile includes AFP, Free Estriol and BhCG.
Note: It is necessary to know the probable date of delivery, the patient's date of birth, weight, race, diabetic status, number of deliveries and if she has a history of neural tube defects for the interpretation of the results.
TRYPTASE
Indications: To collect the sample, the patient must have had an episode or event that causes suspicion of mastocytosis (fainting, sweating, immediate hypersensitivity, anaphylaxis, acute allergic exposure and/or mastocytosis) and take a sample 15 minutes to 3 hours after the event.
Indications: To collect the sample, the patient must have had an episode or event that causes suspicion of mastocytosis (fainting, sweating, immediate hypersensitivity, anaphylaxis, acute allergic exposure and/or mastocytosis) and take a sample 15 minutes to 3 hours after the event.
TRYPTOPHAN
Indications: Fast overnight or for at least 4 hours after eating. Non-fasting samples are accepted in pediatric patients.
Indications: Fast overnight or for at least 4 hours after eating. Non-fasting samples are accepted in pediatric patients.
THROMBOELASTROGRAPHY (TEG)
Type of sample: Citrated whole blood.
clinical significance: Evaluate the different stages of coagulation, minimizing the unnecessary use of blood components.
Type of sample: Citrated whole blood.
clinical significance: Evaluate the different stages of coagulation, minimizing the unnecessary use of blood components.
TROPONIN I
Type of sample: Serum, plasma.
clinical significance: Detect myocardial infarction.
Type of sample: Serum, plasma.
clinical significance: Detect myocardial infarction.
V
vancomycin
Type of sample: Serum, plasma.
clinical significance: The test is useful to monitor the dose and avoid toxicity.
Type of sample: Serum, plasma.
clinical significance: The test is useful to monitor the dose and avoid toxicity.
CHICKENPOX IGM
Type of sample: Serum, plasma.
clinical significance: The test is useful for monitoring Varicella virus infection.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: The test is useful for monitoring Varicella virus infection.
Indications: N/A
SEDIMENTATION RATE
Type of sample: Whole blood (EDTA).
clinical significance: Inflammation, general infection.
Indications: N/A
Type of sample: Whole blood (EDTA).
clinical significance: Inflammation, general infection.
Indications: N/A
HIV (1 + 2) ANTIBODIES
Type of sample: Serum, plasma.
clinical significance: HIV infection. To diagnose perinatal infections (up to 18 m).
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: HIV infection. To diagnose perinatal infections (up to 18 m).
Indications: N/A
HIV VIRAL LOAD
Indications: See HIV Viral Load
Indications: See HIV Viral Load
VITAMIN A (RETINOL)
Indications: You must be fasting.
Indications: You must be fasting.
VITAMIN B1 (THIAMIN)
Indications: Overnight fasting is required.
Indications: Overnight fasting is required.
B12 VITAMIN
Type of sample: Serum, plasma.
clinical significance: Vitamin B12 is required for the proper maturation of red blood cells. Clinical manifestations of Vitamin B-12 deficiency include megaloblastic anemia, swollen tongue with the appearance of raw meat, anorexia, and neurological changes beginning with demyelination.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Vitamin B12 is required for the proper maturation of red blood cells. Clinical manifestations of Vitamin B-12 deficiency include megaloblastic anemia, swollen tongue with the appearance of raw meat, anorexia, and neurological changes beginning with demyelination.
Indications: N/A
VITAMIN B2 (RIBOFLAVIN)
Indications: Overnight fasting is required.
Indications: Overnight fasting is required.
VITAMIN B6 (PYRIDOXAL PHOSPHATE)
Indications: Overnight fasting is preferred. Alternate names: Pyridoxal or Pyridoxal phosphate.
Indications: Overnight fasting is preferred. Alternate names: Pyridoxal or Pyridoxal phosphate.
VITAMIN C (ASCORBIC ACID)
Indications: Night fasting is required, do not take vitamin C or fruit supplements for 24 hours before.
Indications: Night fasting is required, do not take vitamin C or fruit supplements for 24 hours before.
VITAMIN D 25-OH
Type of sample: Serum, plasma.
clinical significance: Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases that impair bone metabolism.
Indications: N/A
Type of sample: Serum, plasma.
clinical significance: Vitamin D deficiency is a cause of secondary hyperparathyroidism and diseases that impair bone metabolism.
Indications: N/A
VITAMIN E
Indications: Patient must be fasting.
Indications: Patient must be fasting.
VITAMIN K
Indications: Fast for a minimum of 8 hours. You must refrain from eating liver and take multivitamins or vitamin K at least 24 hours before sample collection.
Indications: Fast for a minimum of 8 hours. You must refrain from eating liver and take multivitamins or vitamin K at least 24 hours before sample collection.
VMA (VANILMANDELIC ACID)
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Indications: Start urine collection discarding the 1st urine in the morning. Note the collection start time and collect all the urine during the 24 hours. Ask for detailed instructions in the laboratory.
Z
ZINC
Type of sample: Serum, plasma.
clinical significance: You must refrain from taking vitamins or mineral and herbal supplements for at least one week before sample collection.
Type of sample: Serum, plasma.
clinical significance: You must refrain from taking vitamins or mineral and herbal supplements for at least one week before sample collection.
NOTE: IF ANY TEST IS NOT LISTED, CONSULT THE LABORATORY
Related Services
Clínica Hospital San Fernando is the first private hospital in the Republic of Panama.